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ABSTRACT
Introduction Children’s growth status is an important measure 
commonly used as a proxy indicator of advancements in a 
country’s health, human capital and economic development. 
We aimed to assess the feasibility of using Super- Imposition 
by Translation And Rotation (SITAR) models for summarising 
population- based cross- sectional height- by- age data of 
children under 5 years across 64 countries.
Methods Using 145 publicly available Demographic and 
Health Surveys of children under 5 years across 64 low- income 
and middle- income countries from 2000 to 2018, we created a 
multicountry pseudo- longitudinal dataset of children’s heights.
Results SITAR models including two parameters (size and 
intensity) explained 81% of the between- survey variation 
in mean boys’ height and 80% in mean girls’ height. Size 
parameters for boys and girls (relative to the WHO child growth 
standards) were distributed non- normally around a mean of 
−5.2 cm for boys (range: −7.9 cm to −1.6 cm) and −4.9 cm for 
girls (range: −7.7 cm to −1.2 cm). Boys exhibited 10% slower 
linear growth compared with the WHO (range: 19.7% slower to 
1.6% faster) and girls 11% slower linear growth compared with 
the WHO (range: 21.4% slower to 1.0% faster). Variation in the 
SITAR size parameter was ≥90% explained by the combination 
of average length within the first 60 days of birth (as a proxy for 
fetal growth) and intensity, regardless of sex, with much greater 
contribution by postnatal intensity (r≥0.89 between size and 
intensity).
Conclusions SITAR models with two random effects can be 
used to model child linear growth using multicountry pseudo- 
longitudinal data, and thereby provide a feasible alternative 
approach to summarising early childhood height trajectories 
based on survey data. The SITAR intensity parameter may 
be a novel indicator for specifically tracking progress in the 
determinants of postnatal growth in low- income and middle- 
income countries.
INTRODUCTION
The remarkable increases in average height 
of adults across all countries in the last 
century1 2 have been mainly attributed to 
improvements in nutrition, health and living 
conditions.2 These increases have been also 
notable in fundamental secular changes in 
the pattern of child and adolescent growth.3–5 
Children are growing taller than previous 
cohorts, experiencing earlier pubertal growth 
spurt (and earlier general maturation) as 
well as faster rates of growth, especially in 
Key questions
What is already known?
 ► Child height is widely used as an indicator of health, 
human capital and economic development.
 ► Country progress towards achieving the Sustainable 
Development Goals and WHO global targets is con-
ventionally demonstrated by analysing secular 
trends in stunting and/or, less frequently, using mean 
height/length- for- age z- scores (HAZ/LAZ) over time.
What are the new findings?
 ► Super- Imposition by Translation And Rotation (SITAR) 
can be applied to modelling child linear growth using 
cross- sectional data from multicountry Demographic 
and Health Surveys, providing a feasible alternative 
approach to summarising linear growth trajectories 
using cross- sectional data.
 ► SITAR parameters are strongly correlated with stunt-
ing and mean height- for- age.
 ► Postnatal size is explained by the combination of 
average starting length within the first 60 days of 
birth (proxy for fetal growth) and postnatal growth 
intensity.
What do the new findings imply?
 ► The SITAR intensity parameter may be a novel and 
informative indicator for specifically tracking prog-
ress in the determinants of postnatal growth in low- 
income and middle- income countries.
 ► Further research should be conducted on the useful-
ness of the SITAR intensity for describing variations 
in postnatal growth between countries as well as 
within countries over time.
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high- income countries.6 Understanding how and why 
child growth patterns have changed is necessary for char-
acterising global health inequalities as well as predicting 
future secular changes in population height.7
Child height is widely used as an indicator of health, 
human capital and economic development.1–3 The most 
commonly used population indicator based on child 
height is the under-5 stunting prevalence (stunting), 
defined as the proportion of all children between the 
ages of 0 and 5 years whose height- for- age is more than 
2 SD below the median of the WHO child growth stan-
dards for age and sex.8 Reducing the prevalence of 
child stunting is a global public health priority that is 
embedded within the Sustainable Development Goals 
(SDGs)9 and the WHO global targets for 2025, which 
include a 40% reduction in the number of stunted chil-
dren under 5 years.10
Country progress towards achieving SDGs and WHO 
global targets is conventionally demonstrated by analysing 
secular trends in stunting and/or, less frequently, using 
mean length/height- for- age z- scores (LAZ/HAZ) over 
time.1 6 11 12 Most low/middle- income countries (LMICs) 
have high stunting prevalences as well as low mean LAZ/
HAZ,11 13 14 indicating nearly all children in these popula-
tions are, on average, attaining a suboptimal size for age 
and sex relative to healthy children growing in optimal 
conditions.13 Using 179 Demographic and Health Survey 
(DHS) datasets from 64 LMICs (1993–2015), we previ-
ously showed that linear growth faltering is a whole- 
population phenomenon characterised by downward 
shifts in the entire population HAZ distribution rather 
than deviations limited to a small, high- risk subgroup, 
as may be implied by the binary stunting indicator.13 
Stunting is a population- level statistical indicator of chil-
dren’s social and economic deprivation and does not 
equate to malnutrition as commonly used in nutritional 
and epidemiological studies of child health and public 
health programmes.15–18 In addition, binary indicators, 
such as stunting, are more likely to be affected by the 
quality of anthropometric measurements which can vary 
within and between surveys.19 20
We hypothesise that Super- Imposition by Transla-
tion And Rotation (SITAR) random parameters convey 
between- country variations in linear growth in more 
detail than what is captured by conventional cross- 
sectional indicators such as under-5 stunting preva-
lence. Height- derived indicators that capture the whole 
population distribution have potential advantages over 
indicators that identify a subgroup of affected or at- risk 
children, by characterising more nuanced variations in 
age- related linear growth trajectories.
Our goal was to apply the SITAR models to summarise 
and compare population- level child height data across 
a sample of LMICs. The SITAR modelling approach 
for growth data has been demonstrated to efficiently 
summarise growth trajectories relative to an underlying 
population- average height- by- age growth curve and three 
child- specific random effects that reflect between- child 
variations in absolute size (average vertical displace-
ment of a child’s growth curve relative to the population 
mean), intensity (a scaling factor applied to the age scale, 
that reflects relative expansion or contraction of the time 
period of growth), and timing of growth (average lateral 
shift in the child’s growth curve on the age axis).21 An 
advantage of SITAR growth curve analysis is that these 
estimated random parameters are easily interpretable, 
in the original units of the modelled parameter (eg, 
size parameter is expressed in centimetres), and esti-
mates are specific values along a continuous scale that 
can be used in further analyses of child linear growth 
such as exploring their associations with exposures or 
outcomes.22–24 Furthermore, the intensity parameter 
reflects a uniquely postnatal pattern, in contrast to the 
majority of child growth indicators that are expres-
sions of attained size, which reflect both fetal and post-
natal growth. SITAR models have been recently used to 
describe population- average trajectories using country 
cross- sectional data in Japan and South Korea,7 25 but the 
model has not been applied to multicountry survey data 
such as the DHS from LMICs.
The goal of this study was to demonstrate the appli-
cation of SITAR to derive alternative metrics for 
summarising population- level child height data across a 
sample of cross- sectional surveys from LMICs.
METHODS
Data source
We used publicly available DHS anthropometric data 
(length/height, age and sex) for children under 5 years 
across 145 surveys from 64 countries conducted between 
2000 and 2018.26 All available DHS surveys for the study 
period were accessed through the DHS programme 
online repository.26 As described in detail elsewhere,27 28 
children under 2 years were measured in supine position 
(recumbent length), whereas children between 2 and 
5 years were measured standing up (height). We used 
DHS surveys conducted since 2000 because that is when 
the DHS programme employed a standardised ques-
tionnaire and a unified anthropometry data collection 
process across all surveys and all children in the sampled 
households were surveyed. The DHS data are the largest 
nationally representative data available for many LMICs 
as they cover all administrative divisions and districts 
within countries. The DHS are usually conducted every 
3–5 years per country, with the exception of a few coun-
tries that implement continuous DHS, with annual data 
collection. The DHS surveys are cross- sectional studies 
that follow a two- stage stratified random sampling of 
enumeration areas (first stage) and households (second 
stage). All DHS samples are representative at least at 
national and regional levels in all included countries.
Statistical methodology
Many child growth models assume parametric non- linear 
functions (usually exponential) which often fit data 
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poorly, especially during the first year of life.29–31 In 2007, 
Beath32 introduced a considerable simplification to the 
analysis of growth curves by applying previously proposed 
shape invariant models (SIMs)33 to describe infant weight 
trajectories from birth to 2 years of age. SIMs fit a single 
function to a trajectory, and transform it, by shifting and 
scaling, to improve its fit to each subject. This results in a 
single growth curve which can be applied to all subjects 
using three subject- specific translation and rotation para-
maters of the population- average curve to fit individual 
growth curves. This model was later named by Cole et al21 
as the SITAR model.
A key assumption of SITAR is that height trajectories 
assume a common shape when developmental age is used 
as the time scale. In contrast to chronological age (time 
since birth), developmental age is based on markers of a 
child’s growth and development to convey the extent of 
biological maturation from conception to their current 
status. A single population mean curve is fitted as a cubic 
spline function with all individuals assumed to have the 
same underlying shape of the growth curve subject to 
three simple transformations estimated as subject- specific 
random effects that represent deviations from the popu-
lation mean curve.21 In the present study, we considered 
the primary unit of analysis to be the survey, for which 
data (mean height) were available at multiple age inter-
vals between ages 0 and 5 years, and we compared curves 
derived from individual surveys to the WHO child growth 
standards. Applying SITAR, an individual survey- specific 
growth curve has a relationship with the global mean 
curve that is estimated by its deviation up or down from 
the mean curve (differences in mean size represented 
by the random intercept on the height scale) and left or 
right (differences in growth timing represented by the 
random intercept on the chronological age scale), and 
by shrinking or stretching the curve on the age scale to 
indicate how fast average growth is in the survey setting 
(differences in growth rate represented by the random 
slope of growth rate using the chronological age scale). 
Size is expressed in units of the measurement (cm), 
timing in units of age (months) and intensity as a frac-
tion or percentage of the mean growth rate. The SITAR 
growth model is defined by the following equation:
Length/heightit=αi+h[exp(γi)×(t−βi)]+ϵit Equation 1
where length/heightit is the measurement for subject i at 
age t; h(.) is a natural cubic B- spline function in trans-
formed age defining the mean spline curve chosen to 
minimise the Bayesian Information Criterion (BIC); 
αi, βi and γi are survey- specific random effects for size, 
timing and intensity, respectively; and the ϵit are normally 
distributed residuals. Fixed effects for αi, βi and γi are also 
included to ensure the mean random effects are set to 
zero. Note that γ is exponentiated to provide a multi-
plier centred on one. For all surveys, trajectories are 
estimated separately for each sex and for countries with 
multiple surveys, trajectories were modelled by year as 
well. The SITAR model fit is based on a non- linear mixed- 
effect (NLME) model and estimation is by maximum 
likelihood.34 A best linear unbiased prediction of each of 
the random effects for each survey (equivalent to subjects 
in the conventional application of SITAR) was used to 
obtain survey- specific predicted curves.35
Data analysis
The dataset includes 1 351 926 individual children across 
the surveys. Of the total number of eligible children 0–59 
months of age, 37 671 (2.8%) were excluded as they were 
not de facto members of the household (ie, had not slept 
in the household the previous night).36 Age was consid-
ered missing if month and/or year of birth was missing. 
If month and year of birth was only available, the day 
of birth was imputed as 15. Exclusions due to missing 
age, sex or height data totalled 77 131 (5.7%) children 
(figure 1). We then applied the 2006 WHO standard37 
macro to the raw DHS height data to derive estimates for 
HAZ and prevalence of stunting among children 0–59 
months of age. Data were excluded if a child’s HAZ was 
below −6 SD or above +6 SD (most likely a result of errors 
in measurement or data entry), as recommended by the 
WHO,38 for a total of 28 641 (2.1%) excluded children, 
resulting in a sample size of 1 208 483 (89%) children 
(figure 1). All estimates of mean HAZ and prevalence 
of stunting were calculated accounting for DHS sample 
survey weights to make sample data representative of the 
entire population.
A pseudo- longitudinal dataset was created from cross- 
sectional data by summarising all observations of chil-
dren’s heights within each survey into a single trajectory 
from birth to 5 years of age for each sex (and survey year 
in the case of countries with multiple surveys). To account 
for sampling variations by age and across surveys and also 
ensure height measurements increased monotonically 
with age, individual child- level height data in each DHS 
were binned in 2- month child age intervals and a mean 
height was obtained for each interval. Each country, 
survey year and sex was thus represented by 30 interval- 
specific mean heights. For 41 countries, more than one 
survey was available. For example, we included six surveys 
from Peru (in survey years 2005, 2007, 2008, 2009, 2010 
and 2012), thereby generating six growth trajectories (ie, 
curves) for boys and six trajectories for girls.
To enable expression of survey- specific parameters rela-
tive to the WHO child growth standards rather than the 
empirical sample mean (of all 145 surveys), we included 
the mean height for boys and girls according to the WHO 
child growth standards for ages 0–5 years8 as one of the 
surveys (total n=146 surveys). The mean heights of WHO 
child growth standards included were estimated for the 
same 30 intervals used for the DHS. The SITAR growth 
models were then applied to the dataset comprised of 
4380 height data points for boys and 4380 for girls (ie, 
30 data points across 146 ‘surveys' for each sex) to esti-
mate the SITAR parameters for the WHO reference data 
along with those from 145 DHS data. Separate models 
were fit for boys and girls.39 We re- parameterised the 
SITAR random effects in relation to the WHO reference 
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by subtracting the WHO SITAR random effects from the 
random effects of each of the 145 DHS (online supple-
mental file 1).
We experienced convergence issues for some models 
and in such instances we applied commonly recom-
mended transformation approaches such as log transfor-
mation of either height, age or both, and also explored 
dropping one of the random effects.25 40 In addition, the 
SITAR models were optimised by choosing the df for 
the cubic B- spline curve to minimise the BIC.41 SITAR 
model convergence was not achieved for the full model 
with three random effects. The timing parameter was 
dropped because it showed the least variability across 
the surveys leading to a simplified SITAR model given 
by:
Length/heightit=αi + h[exp(γi)×t]+ϵit. Equation 2
where length/heightit is the measurement for subject i at 
age t; h(.) is a natural cubic B- spline function in trans-
formed age defining the mean spline curve; and αi and γi 
are survey- specific random effects for size and intensity, 
respectively, and the ϵit are normally distributed resid-
uals. The difference between equation 2 of SITAR and 
the more conventional mixed- effects model, the random- 
intercept- random- slope (RIRS) model, is that SITAR 
applies the scale factor to the age axis whereas RIRS 
scales the height axis.
Models were evaluated by comparing the BIC of 
different models. We quantified the percentage variance 
in height that was explained by each SITAR model using:
% variance in height explained=100×(1−(σ2/σ1)
2) 
where σ1 is the fixed- effects residual SD (RSD) and σ2 the 
SITAR random- effects RSD, that is, the SD of the spread 
of the data points around the fitted curve.42
The BIC penalises the deviance by loge(n) units for each 
additional df where n is the sample size. Better models 
have a lower BIC value. Height was modelled in the orig-
inal scale (centimetres) whereas age in months was log 
transformed for all models. We used the dfset command 
available in the sitar package in R43 to determine the 
appropriate number of df (knots) for a natural spline 
curve that minimised the BIC for our fitted models. All 
models were fit with 4 df.
Having obtained the SITAR- fitted random effects for 
each survey- year and sex, we correlated the two SITAR 
parameters with each other, and also with stunting preva-
lence and mean HAZ. As age was aggregated in 2- month 
child age intervals, the earliest aggregated mean length 
was within the first 60 days of birth and therefore used 
as a proxy for ‘starting size’ (reflecting fetal growth). To 
partition postnatal size into its components of ‘starting 
size’ (reflecting fetal growth) and postnatal velocity, we 
performed correlation analyses of the SITAR size and 
Figure 1 Flow chart for 145 Demographic and Health surveys from 64 countries between 2000 and 2018. de facto children 
refer to members of the household 0 to 59 months of age who slept in the household the previous night whereas de jure refer 
to members of the household 0 to 59 months of age who did not sleep in the household the previous night. HAZ, height- for- 
age z- scores.
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intensity parameters with mean length within the first 60 
days of birth. We then estimated a multiple linear regres-
sion model with SITAR size parameter as the outcome 
and both intensity and average length within the first 60 
days of birth as covariates.
Since 41 countries contribute more than one trajec-
tory, we performed sensitivity analyses by repeating the 
analysis using only the most recent survey from each 
country. Additional subgroup analyses were performed 
by fitting SITAR models to DHS data classified according 
to World Bank regions.44
The models were fit in statistical software R using the 
nlme package,34 Tim Cole’s sitar package43 (https:// 
rdrr. io/ cran/ sitar/) and STATA V.15 (College 
Station, Texas, USA). The R- code used to perform all 
the analyses is provided in online supplemental file 2.
Patient and public involvement
Our study does not involve the participation of 
patients or any members of the public. All data used in 
this study are aggregated and publicly available DHS 
anthropometric data and can be accessed through the 
DHS programme online repository.26
RESULTS
The weighted median sample size, median age in 
months and percentage of boys for each of the six 
world regions are summarised in table 1. Most surveys 
were from the sub- Saharan Africa region followed 
by Latin America and the Carribean, Europe and 
Central Asia, South Asia, North Africa and the Middle 
East (table 1). The median number of children per 
survey was 5473 (~90 children in each month); 82% 
included between 1000 and 10 000 children, and the 
median age was 29.6 months (IQR: 14.6–44.4 months) 
(online supplemental file 3).
Of the models that achieved convergence, those 
containing two random effects (size and intensity) fit 
best based on the BIC (table 2). The final selected 
models (table 3) explained 81% and 80% of the 
between- survey variation in mean height for boys 
and girls, respectively (table 2; Figures 2 and 3). Two 
example surveys and the WHO child height standards 
were used to illustrate that the modelled trajectories 
closely fit the observed data (online supplemental file 
4). As expected, there were negligible differences in 
size (maximum difference was <0.05 cm for girls and 
boys) and intensity (maximum difference was <0.2% 
for boys and girls) between the random effects gener-
ated with and without inclusion of the WHO data in 
the multicountry dataset (online supplemental files 5 
and 6).
Fitted growth trajectories for boys and girls were 
below the WHO child growth standards for all surveys 
(figure 4). Sex- specific height- by- age and velocity- 
by- age curves were similarly shaped although boys 
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parameters for boys (relative to the WHO growth 
reference) were distributed non- normally with a 
mean of −5.2 cm (shorter) compared with the refer-
ence (figure 5), and ranging from −7.9 cm (Niger 
2006) to −1.6 cm (Armenia 2016). Girls were, on 
average, −4.9 cm below the WHO reference median 
(figure 5), ranging from −7.7 cm (Nepal 2001) to −1.2 
cm (Armenia 2016). Across all surveys, boys’ intensity 
parameter was 10% below the WHO intensity refer-
ence, ranging from 19.7% below (Niger 2006) to 1.6% 
above the reference (Armenia 2016). Similarly, girls 
exhibited 11% lower intensity, on average, compared 
with the WHO reference (figure 5), with cross- survey 
values ranging from 21.4% below (Ethiopia 2000) to 
1.0% above the reference (Armenia 2016).
Size and intensity parameters were highly correlated 
(r=0.91 for boys; r=0.89 for girls) (online supple-
mental file 7), such that intensity explained ~80% of 
the variability in size for boys and girls. The mean HAZ 
was perfectly correlated with the SITAR size param-
eter (r=1) for boys and girls. Prevalence of stunting 
was highly correlated with the SITAR size parameter 
(r=−0.96 for boys and r=−0.97 for girls). The correla-
tion of stunting with SITAR intensity parameter was 
also strong (r=−0.91 for boys; r=−0.90 for girls) and 
the mean HAZ was highly correlated with the SITAR 
intensity (r=0.89 for girls and r=0.91 for boys) (online 
supplemental files 8 and 9).
Results of the sensitivity analyses to evaluate the 
impact of varying number of surveys between coun-
tries (145 surveys compared with 64 latest surveys) 
were remarkably similar to the main findings despite 
the more than 50% reduction in the number of surveys 
(online supplemental file 10). The subgroup anal-
yses of fitted SITAR models to DHS data according to 
World Bank regions showed the percentage variability 
in mean height ranged between 70%–84% in boys and 
69%–82% in girls. Model convergence was not achieved 
for two regions (East Asia and Pacific and Europe and 
Central Asia) which had the least number of countries, 
that is, ≤10 countries (online supplemental file 11).
The correlation of the size parameter with average 
length within the first 60 days of birth was moderate 
(r=0.41 for boys and r=0.43 for girls), but the correla-
tion of intensity with average length within the first 
60 days of birth was low (r=0.14 for boys and r=0.16 
for girls). The combination of average starting length 
within the first 60 days of birth and postnatal inten-
sity in both models for boys and girls explained more 
than 90% of the variability in postnatal size (online 
supplemental file 12).
Table 2 Comparison of SITAR models applied to Demographic and Health Survey data from 145 surveys (64 countries) from 
2000 to 2018








  M1 Absolute size Absolute size 14 298 68.5
  M2* Absolute size+intensity Absolute size+intensity 12 471 80.6






  F1 Absolute size Absolute size 14 253 67.7
  F2* Absolute size+intensity Absolute size +Intensity 12 421 80.2





Age in months was log transformed for all models; all models were fit using 4 df.
*Final model selected.
N/A, not applicable; SITAR, Super- Imposition by Translation And Rotation.
Table 3 Best- fitting SITAR models for boys and girls 
applied to Demographic and Health Survey mean height 
data from 145 surveys (64 countries) from 2000 to 2018
Mean height (cm)
Estimate±SE
Fixed coefficients Boys Girls
Size (cm) 58.97±1.14 53.47±1.71
Intensity (fractional) 0.30±0.06 0.08±0.08
Random coefficients
Standard deviations (SD)
  Size 1.46 1.42
  Intensity 0.05 0.05
Residual SD 0.90 0.89
Degrees of freedom 4 4
All models were adjusted for age in months (log transformed).
.SE, Standard error; SITAR, Super- Imposition by Translation And 
Rotation.
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DISCUSSION
We have demonstrated that a commonly used statis-
tical method for modelling adolescent growth at 
individual level (SITAR) can be feasibly applied to 
describe population- average patterns of early child 
linear growth across a set of anthropometric survey 
datasets. The SITAR random effects efficiently summa-
rise country- specific height trajectories for children 
0–5 years of age using cross- sectional survey data. The 
final model, including two random effects (size and 
intensity) explained over 80% of the between- survey 
variability in mean height for boys and girls, high-
lighting a between- country consistency of the shape 
of the mean postnatal linear growth trajectory despite 
the surveys being conducted in diverse geographical 
contexts and over a span of 18 years.13 45 Sensitivity 
analyses performed using only the most recent survey 
for each country with much improved data quality 
revealed minimal differences between the fitted 
population mean curves, providing confidence in the 
robustness of our final selected SITAR models.
A subgroup analyses performed separately on each of 
the six defined World Bank regions showed substantial 
differences in the amount of variability in mean height 
(in both boys and girls) that was explained by the fitted 
SITAR models that converged. The percentage vari-
ance in mean height (in both boys and girls) that was 
explained was lowest in sub- Saharan Africa and South 
Asia. We do not know the reason for the lowerpercentage 
variability explained in these two regions but note that 
(1) sub- Saharan Africa and South Asia have the highest 
prevalence of stunting and shorter height on average 
compared with the other regions; and (2) each country 
dataset includes cohorts of children across 5 different 
years, such that any acute health shock (eg, humanitarian 
disaster) affecting one cohort more than others would 
affect the age- related trajectories and could therefore 
affect how much variability is explained by the SITAR 
models; such health shocks are likely more common 
in sub- Saharan Africa and South Asia than other world 
regions.
SITAR was originally developed to model individual 
child or adolescent trajectories using longitudinal data. 
However, Cole and Mori25 and Schneider and Ogasawara7 
have recently demonstrated the application of SITAR to 
cross- sectional height and weight data by sex between the 
ages of 1 and 20 years (Cole and Mori), and also for cross- 
sectional height data among children aged 6–18 years 
(Schneider and Ogasawara). In both examples, the data 
have been grouped in 1- year bins for modelling. Here, we 
extend this application of the SITAR model to population- 
based cross- sectional surveys of children under-5 years 
from 64 LMICs with high prevalence of linear growth 
deficits.11 13 46 Characterisation of the population- average 
child growth trajectories using the SITAR parameters in 
our study confirmed that in resource- limited settings, 
Figure 2 Mean height trajectories for boys (top panels) and girls (bottom panels) before (left panels) and after (right panels) 
adjustment using SITAR size and intensity parameters, for 145 Demographic and Health Surveys from 64 countries. SITAR, 
Super- Imposition by Translation And Rotation.
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mean population heights and mean growth intensity 
are below those expected using the WHO child growth 
reference, and the deficits worsen with age.13 46 Our esti-
mates based on raw length/height- for- age data reveal 
that the size and growth intensity deficits continue to 
accrue through to age 5 years, corroborating inferences 
from studies using height- for- age difference that suggest 
that linear growth faltering continues past the point at 
which HAZ trajectories appear to plateau.47 The intensity 
parameter is a proxy for speed of maturation and conse-
quently, low intensity reflects linear growth faltering.
The main motivation for using SITAR in this context 
was to identify alternative or complementary metrics for 
summarising child linear growth and tracking country prog-
ress. In contrast to conventional cross- sectional indicators such 
as under-5 stunting prevalence and mean HAZ, the SITAR 
parameters are derived by explicitly assuming that there is 
a linear relationship between chronological age and devel-
opmental age and subsequently modelling each component 
on the proper scale (size on the height scale, and intensity 
and timing on the age scale), thereby estimating biologically 
relevant non- linear trajectories for each component. We had 
hypothesised that these parameters would convey between- 
country variations in linear growth in more detail than what is 
captured by traditional cross- sectional aggregated measures, 
such as under-5 stunting prevalence. However, empirically 
we found very high correlations between the prevalence of 
stunting (and mean HAZ) and the size and intensity param-
eters; in fact, the correlations were nearly perfect for the 
size parameter. The near perfect correlation between the 
size parameter and the prevalence of stunting (and mean 
HAZ) suggests that inequities in size between countries esti-
mated using SITAR are identical to those observed when 
comparing mean HAZ or stunting prevalences. Since the 
SITAR size parameter is nearly exchangeable with those indi-
cators, there may be no advantage to estimating SITAR solely 
to derive the size parameter, particularly given the relative 
complexity of SITAR modelling. In contrast, the intensity 
parameter had a somewhat weaker correlation with mean 
HAZ and stunting prevalence and therefore may provide 
complementary information. We found that in both boys 
and girls, more than 90% of the variability in postnatal size 
represented by the SITAR size parameter was explained by 
the combination of average length within the first 60 days of 
birth and postnatal intensity. Most of the variation was attrib-
utable to postnatal intensity, which was nearly independent 
of very early postnatal size (a proxy for fetal growth). Thus, 
unlike conventional height- derived indicators that are based 
on attained size alone, SITAR partitions size into two compo-
nents—fetal growth (captured by size at or near birth) and 
postnatal growth (represented by the intensity parameter). 
We have demonstrated that the intensity parameter on its 
own may serve as a specific measure of the postnatal experi-
ence to a much greater extent independent of the prenatal 
Figure 3 An illustration of the SITAR transformation of a crude height trajectory for a given survey to the population- level 
average modelled trajectory shown using height trajectory for boys in Malawi in the 2004 survey before SITAR adjustment 
(solid green line, left panel) and after SITAR adjustment (dotted green line, left panel); Egypt 2014 survey for boys, before 
SITAR adjustment (solid green line, right panel) and after SITAR adjustment (dotted green line, right panel). The fitted SITAR 
population- mean curve is shown by solid black line in both plots. SITAR, Super- Imposition by Translation And Rotation.
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period compared with the size parameter; the size param-
eter (similar to stunting prevalence and mean HAZ) is a 
composite of both the prenatal (fetal growth) and postnatal 
period (infant/child growth) periods.
In the assessment of our primary objective which was to 
assess the feasibility of using SITAR models for summarising 
multicountry comparisons of population- based cross- 
sectional data from 0 to 5 years, we experienced some chal-
lenges with SITAR regarding convergence issues for some of 
the models. The random effect that represents timing did 
not vary across surveys and convergence was only achieved 
after excluding this random effect from the model. Notably, 
this parameter has no clear meaning for the linear growth 
of children below 5 years of age where peak velocity is not 
present as a prominent feature within the observation period 
in contrast with growth during adolescence, where SITAR is 
more commonly applied. SITAR is a complex non- linear 
model that may require a combination of variable transforma-
tions and model fit optimisation in order to achieve conver-
gence. Convergence was not achieved in all world regions, 
and the lower variability explained in sub- Saharan Africa 
and South Asia suggests that perhaps additional parameters 
are required (eg, a timing parameter). SITAR assumes no 
measurement error when in fact there is probably differential 
measurement error across surveys due to differences in data 
quality across surveys (both across years and across coun-
tries), whether children were measured lying down or 
standing up, difficulty to obtain accurate measurements of 
length/height of children in the field especially for younger 
children, and the impact of associated measurement errors 
in age and height.19 20 Our analyses combined children born 
at different years to form a cohort and this approach could 
potentially introduce bias especially if selected cohorts were 
exposed to health shocks to a greater extent than other chil-
dren included in the same survey. Furthermore, the current 
formulation of SITAR does not account for survey design or 
clustering of observations as the number of surveys differed 
by country.
In conclusion, we applied SITAR for modelling child 
height- for- age based on cross- sectional data from multi-
country surveys, and demonstrated that SITAR models with 
two random effects provide a feasible alternative approach 
to summarising child length/height trajectories for popula-
tions based on survey data. Although the estimated SITAR 
parameters (size and intensity) were strongly correlated 
with more conventional indicators such as prevalence of 
stunting and mean HAZ, the SITAR intensity parameter 
may be a novel indicator for specifically tracking progress 
Figure 4 Smoothed- fitted height curves for each survey for boys (grey, top- left panel) and the median WHO boys height 
trajectory (solid blue line, top- left panel); girls (grey, top- right panel) and the median WHO girls height trajectory (solid red line, 
top- right panel). The bottom- left panel shows a comparison of the fitted mean population height- by- age curve for boys (blue) 
and girls (red), and the bottom- right panel shows the corresponding height velocity- by- age curve for boys (blue) and girls (red).
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in the determinants of postnatal growth in LMICs. Further 
research will therefore focus on whether the intensity param-
eter is practically useful for describing variations in postnatal 
growth between countries as well as within countries over 
time, that are not fully captured by traditional indicators 
such as stunting prevalence and mean HAZ.
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1 Reparameterization of SITAR’s random effect
The SITAR growth curve is a shape-invariant growth that assumes all individ-
uals to have the same underlying shape of the growth curve [1, 2]. The SITAR
formula is expressed as:






where yit is the measurement for subject i at age t; αi, βi, and γi are, respec-
tively, size, tempo, and intensity random effects; h(·) is a cubic regression spline
curve; and ǫit are independent normally distributed errors.
To reparameterize the intensity random parameter γi;




, equation 1 becomes:













Equation 2 can thus be generalized to:







A general form of the new reparametrized intensity parameter based on γw for
each individual can thus be obtained as γi − γw
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Supplementary File 2: R code used for the SITAR analysis 
rm(list=ls(all=TRUE)) 
require(gamlss, haven, foreign, sitar, fdapace, hbgd, dplyr, ggplot2, ggpubr, growthstandards, 
PerformanceAnalytics) 
# install.packages("remotes") # if "remotes" is not already installed 
# remotes::install_github("ki-tools/growthstandards") 
 
#### DHS HEIGHT DATA #### 
dhs <- read.dta("DHS_ALL_DATA_WHO.dta") # Read DHS data  
# Males 
dhs_b <- subset(dhs, sex=="male") # selects male height 
dhs_b$year <- as.factor(dhs_b$year) #sets year as a factor variable 
dhs_b$country <- as.factor(dhs_b$country) #sets country as a factor variable 
# Determining the appropriate number of degrees of freedom (knots) 
dfset(ageint_mths, height, dhs_b, FUN=BIC, plot=TRUE) # untransformed age: df = 11 
dfset(log(ageint_mths), height, dhs_b, FUN=BIC, plot=TRUE) # log-transformed age: df = 4 
 
# fit sitar model of height vs log-transformed age 
# checking the influence of each SITAR parameter 
m1 <- sitar(x=log(ageint_mths), y=height, id=id, df=4, data=dhs_b, random='a')  
# fits sitar using 'a' as fixed and random effect 
 
m2 <- sitar(x=log(ageint_mths), y=height, id=id, df=4, data=dhs_b, fixed='a+c', random='a+c')  
# fits sitar using 'a+c' as fixed and random effects  
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 3 
m3 <- sitar(x=log(ageint_mths), y=height, id=id, df=4, data=dhs_b, random='a+c')  
# fits sitar using 'a+c' as fixed and random effects 
 
 
# male <- sitar(x=log(ageint_mths), y=height, id=id, df=4, data=dhs_b,random='a+b+c')  
# fits sitar using 'a+b+c' as fixed and random effects # Did not converge 
 
summary(m3)  
intervals(m3) # generates the 95% CI for the SD of random effects  
 
# Females 
dhs_g <- subset(dhs, sex=="female") # selects female height 
dhs_g$year <- as.factor(dhs_g$year)  
dhs_g$country <- as.factor(dhs_g$country)  
 
# Determining the appropriate number of degrees of freedom (knots) 
dfset(ageint_mths, height, dhs_g, FUN=BIC, plot=TRUE) # untransformed age: df = 11 
dfset(log(ageint_mths), height, dhs_g, FUN=BIC, plot=TRUE) # log-transformed age: df = 4 
# fit sitar model of height vs log-transformed age 
# checking the influence of each SITAR parameter 
m4 <- sitar(x=log(ageint_mths), y=height, id=id, df=4, data=dhs_g, random='a')  
# fits sitar using 'a' as fixed and random effect 
m5 <- sitar(x=log(ageint_mths), y=height, id=id, df=4, data=dhs_g, fixed='a+c', random='a+c')  
# fits sitar using 'a+c' as fixed and random effects  
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Global Health
 doi: 10.1136/bmjgh-2020-004107:e004107. 6 2021;BMJ Global Health, et al. Ohuma EO
 4 
 
m6 <- sitar(x=log(ageint_mths), y=height, id=id, df=4, data=dhs_g, random='a+c')  
# fits sitar using 'a+c' as fixed and random effects  
# female <- sitar(x=log(ageint_mths), y=height, id=id, df=4, data=dhs_g,random='a+b+c')  
# fits sitar using 'a+b+c' as fixed and random effects  
summary(m6) 
intervals(m6) # generates the 95% CI for the SD of random effects 
varexp(pattern='m') # variance explained by each model 
BICadj(pattern='m') # BIC for each model 
AICadj(pattern='m') # AIC for each model 
# Models m3 for boys and m6 for girls selected as final models 
 
## Figure 2 
par(mfrow=c(2,2)) 
mplot(x = ageint_mths, y = height, id = id, vlim=c(50, 120), xlim=c(0,60),data = dhs_b, col = id, 
las = 1, axes=FALSE, 
      ylab="Height (cm)", xlab="Age in months",main="Boys height: raw")  
axis(side=1, at=seq(0, 60, by=12)) 
axis(side=2, at=seq(50, 120, by=20),las=1) 
 
plot(m3, opt = 'a', col = id, vlim=c(50, 120), xlim=c(0,60),las = 1, axes=FALSE, 
     ylab="Height (cm)", xlab="Age in months", 
     main="Boys height: SITAR adjusted") 
axis(side=1, at=seq(0, 60, by=12)) 
axis(side=2, at=seq(50, 120, by=20),las=1) 
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mplot(x = ageint_mths, y = height, id = id, ylim=c(50, 110), xlim=c(0,60),data = dhs_g, col = id, 
las = 1, axes=FALSE, 
      ylab="Height (cm)", xlab="Age in months",main="Girls height: raw") 
axis(side=1, at=seq(0, 60, by=12)) 
axis(side=2, at=seq(50, 110, by=20),las=1) 
 
plot(m6, opt = 'a', col = id, las = 1, ylim=c(50, 110), xlim=c(0,60),axes=FALSE, 
     ylab="Height (cm)", xlab="Age in months", 
     main="Girls height: SITAR adjusted") 
axis(side=1, at=seq(0, 60, by=12)) 
axis(side=2, at=seq(50, 110, by=20),las=1) 
 
## Figure 3 
par(mfrow=c(1,2))  
Malawi_ht_boys <- plot(m1, opt = 'd', lty = 1, col="black", axes=FALSE,lwd=0.5, 
                       ylab="Height (cm)", xlab="Age in months", 
                       main="Boys height (Malawi 2004 survey)") 
axis(side=1, at=seq(0, 60, by=12)) 
axis(side=2, at=seq(40, 120, by=20),las=1) 
lines(m1, opt = 'u', subset = id == 27, col="green", lty=1)  
lines(m1, opt = 'a', subset = id == 27, col="green", lty=2)  
legend('bottomright', c('mean', 'Unadj.MAL.2004', 'Adj.MAL.2004'),  
       lty = c(1, 1, 2), col = c("black", "green", "green"), cex = 0.8, inset=0.04) 
legend('topleft', c('Size: a = -2.2', 'Intensity: c = -0.05'), cex = 0.8, inset=0.04) 
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Egypt_ht_boys <- plot(m1, opt = 'd', lty = 1, col="black", axes=FALSE,lwd=0.5, 
                      ylab="Height (cm)", xlab="Age in months", 
                      main="Boys height (Egypt 2014 survey)") 
axis(side=1, at=seq(0, 60, by=12)) 
axis(side=2, at=seq(40, 120, by=20),las=1) 
lines(m1, opt = 'u', subset = id == 117, col="green", lty=1)  
lines(m1, opt = 'a', subset = id == 117, col="green", lty=2)  
legend('bottomright', c('mean', 'Unadj.EGY.2014', 'Adj.EGY.2014'),  
       lty = c(1, 1, 2), col = c("black", "green", "green"), cex = 0.8, inset=0.04) 
legend('topleft', c('Size: a = 2.4', 'Intensity: c = 0.08'), cex = 0.8, 
inset=0.04) 
## Supplementary Figure 4 
par(mfrow=c(2,2)) 
par(mar = c(4,4,2,2) + 0.1, cex = 0.8) 
plot(height ~ ageint_mths, data = dhs_b, ylim=c(50, 110),las=1,subset = id == 118, main="Boys: 
Egypt 2014", 
     ylab="Height (cm)", xlab="Age in months") 
lines(m3, opt = 'D', subset = id == 118, lty = 1, col="blue") 
lines(m3, opt = 'd', lty = 2, col="red") 
legend('bottomright', c('Observed', 'Fitted trajectory', 'SITAR average-mean curve'),  
       lty = c(NA, 1, 2), pch=c(1,NA,NA), col = c("gray", "blue", "red"), cex = 0.8, inset=0.04) 
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plot(height ~ ageint_mths, data = dhs_g, las=1,ylim=c(50, 110), xlim=c(0,60),subset = id == 104, 
main="Girls: Peru 2012", 
     ylab="Height (cm)", xlab="Age in months",pch=1) 
lines(m6, opt = 'D', subset = id == 104, lty = 1, col="blue") 
lines(m6, opt = 'd', lty = 2, col="red") 
legend('bottomright', c('Observed', 'Fitted trajectory', 'SITAR average-mean curve'),  
       lty = c(NA, 1, 2), pch=c(1,NA, NA), col = c("gray", "blue", "red"), cex = 0.8, inset=0.04) 
 
plot(height ~ ageint_mths, data = dhs_b, ylim=c(50, 110),las=1,subset = id == 146, main="Boys: 
WHO height standards", 
     ylab="Height (cm)", xlab="Age in months") 
lines(m3, opt = 'D', subset = id == 146, lty = 1, col="blue") 
lines(m3, opt = 'd', lty = 2, col="red") 
legend('bottomright', c('WHO height standards', 'Fitted trajectory', 'SITAR average-mean 
curve'),  
       lty = c(NA, 1, 2), pch=c(1,NA,NA), col = c("gray", "blue", "red"), cex = 0.8, inset=0.04) 
 
plot(height ~ ageint_mths, data = dhs_g, las=1,ylim=c(50, 110), xlim=c(0,60),subset = id == 146, 
main="Girls: WHO height standards", 
     ylab="Height (cm)", xlab="Age in months",pch=1) 
lines(m6, opt = 'D', subset = id == 146, lty = 1, col="blue") 
lines(m6, opt = 'd', lty = 2, col="red") 
legend('bottomright', c('WHO height standards', 'Fitted trajectory', 'SITAR average-mean 
curve'),  
       lty = c(NA, 1, 2), pch=c(1,NA, NA), col = c("gray", "blue", "red"), cex = 0.8, inset=0.04) 
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# WHO CHILD GROWTH STANDARDS DATA 
# HEIGHT 
#install.packages("remotes") # if "remotes" is not already installed 
#remotes::install_github("ki-tools/growthstandards") 
who_medht <- data.frame(x = rep(seq(0, 1826.25, length = 61))) 
 
who_medht_boys <- data.frame(who_centile2value(who_medht, p = 50, 
                                               x_var = "agedays", y_var = "htcm", sex = "Male", data = NULL)) # Boys 
who_medht_girls <- data.frame(who_centile2value(who_medht, p = 50, 
                                                x_var = "agedays", y_var = "htcm", sex = "Female", data = NULL)) # 
Girls 
 
who_medht <- cbind(who_medht, who_medht_boys,who_medht_girls) 
colnames(who_medht) <- c("ageint_mths","WHO_ht_P50_boys","WHO_ht_P50_girls") 
head(who_medht) 
who_medht$ageint_mths <- (who_medht$ageint_mths)/30.4375 # convert to months 
 
### Figure 4 
who_medht<-subset(who_medht, ageint_mths>1) 
par(mfrow=c(2,2))  
par(mar = c(4,4,1,1) + 0.1, cex = 0.8) 
plot(m3, opt = 'D', col = 8, las = 1, axes=FALSE,subset=id<146, 
     ylab="Height (cm)", xlab="Age in months", 
     main="Boys height") 
axis(side=1, at=seq(0, 60, by=12)) 
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axis(side=2, at=seq(50, 110, by=20),las=1) 
lines(m3, opt = 'd', lty = 2, col=4) 
lines(m3, opt = 'D', subset=id==146,col="blue",type="l") 
#lines(x=who_medht$ageint_mths, y=who_medht$WHO_ht_P50_boys, col='blue', type='l') 
legend('topleft', c('fitted', 'mean', 'WHO'),  
       lty = c(1, 2, 1), col = c(8, 4, 4), cex = 0.8, inset=0.04) 
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plot(m6, opt = 'D', col = 8, las = 1, axes=FALSE,subset=id<146, 
     ylab="Height (cm)", xlab="Age in months", 
     main="Girls height") 
axis(side=1, at=seq(0, 60, by=12)) 
axis(side=2, at=seq(50, 110, by=20),las=1) 
lines(m6, opt = 'd', lty = 2, col=2) 
lines(m6, opt = 'D', subset=id==146,col="red",type="l") 
#lines(x=who_medht$ageint_mths, y=who_medht$WHO_ht_P50_girls, col='red', type='l') 
legend('topleft', c('fitted', 'mean', 'WHO'),  
       lty = c(1, 2, 1), col = c(8, 2, 2), cex = 0.8, inset=0.04) 
 
plot(m3, opt = 'd', las = 1, apv = FALSE,col="blue",axes=FALSE,ylim=c(50,110), 
     ylab="Height (cm)", xlab="Age in months", 
     main="Fitted height for boys and girls") 
axis(side=1, at=seq(0, 60, by=12),las=1) 
axis(side=2, at=seq(50, 110, by=20),las=1) 
lines(m6, opt = 'd', las = 1, apv = FALSE, col="red", lty = 1) 
legend("topleft", legend = c("Boys","Girls"), col = c('blue','red'),lwd = c(1, 1)) 
 
plot(m3, opt = 'v', las = 1, lty=1, apv = FALSE,col="blue",axes=FALSE,ylim=c(0,8),vlim=c(0,8), 
     vlab="Height velocity (cm/month)", xlab="Age in months", 
     main="Fitted height velocity for boys and girls") 
axis(side=1, at=seq(0, 60, by=12),las=1) 
axis(side=2, at=seq(0, 8, by=1),las=1) 
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lines(m6, opt = 'v', las = 1, apv = FALSE, col="red", lty = 1) 
#points(t(getPeakTrough(dhs_b$ageint_mths, dhs_b$height, peak=FALSE)), pch=25) 
legend("topleft", legend = c("Boys","Girls"), col = c('blue','red'),lwd = c(1, 1)) 
 
 
# Random effects for boys 
ranef(m3) # SITAR random effects for boys 
# Attaching the random effects a and c to the data 
random.ht.b<-m3$coefficients$random$id[dhs_b$id,] 
colnames(random.ht.b)<-c("a_male_ht", "c_male_ht") 
fit_male<-m3$fitted # Renaming the columns in m1$fitted from "fixed" and "id" to "Male fixed 
effect" and "Male predicted height" 
colnames(fit_male)<-c("Male_Fixed_Effect_HT","Male_Predicted_HT") 
dhs_b2<-cbind(random.ht.b,fit_male,dhs_b) 
dhs_b2 <- dhs_b2[order(dhs_b2$a_male_ht),] 
 
# Calculating a and c relative to the WHO random effects 
a_male_ht = dhs_b2$a_male_ht-5.12974361 
c_male_ht = dhs_b2$c_male_ht-0.1030932912 
dhs_b2 = cbind(a_male_ht, c_male_ht, dhs_b2$mean_LAZ, dhs_b2$meanStunting_weighted, 
dhs_b2$year, dhs_b2$pickcountry, dhs_b2$id) 
colnames(dhs_b2)<-c("male_size_ht", "male_velocity_ht", "mean_HAZ", "Stunting", 
"year","country","id") 
dhs_b2 = as.data.frame(dhs_b2) 
 
# Random effects for girls 
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ranef(m6) # SITAR random effects for girls 
# Attaching the random effects a and c to the data 
random.ht.g<-m6$coefficients$random$id[dhs_g$id,] 
colnames(random.ht.g)<-c("a_female_ht", "c_female_ht") 
fit_female<-m6$fitted # Renaming the columns in m1$fitted from "fixed" and "id" to "Male 
fixed effect" and "Male predicted height" 
colnames(fit_female)<-c("Female_Fixed_Effect_HT","Female_Predicted_HT") 
dhs_g2<-cbind(random.ht.g,fit_female,dhs_g) 
dhs_g2 <- dhs_g2[order(dhs_g2$a_female_ht),] 
 
# Calculating a and c relative to the WHO random effects 
a_female_ht = dhs_g2$a_female_ht-4.909995490 
c_female_ht = dhs_g2$c_female_ht-0.1131823325 
dhs_g2 = cbind(a_female_ht, c_female_ht, dhs_g2$mean_LAZ, 
dhs_g2$meanStunting_weighted, dhs_g2$year,dhs_g2$pickcountry,dhs_g2$id) 
colnames(dhs_g2)<-c("female_size_ht", "female_velocity_ht", "mean_HAZ","Stunting", 
"year","country","id") 
dhs_g2 = as.data.frame(dhs_g2) 
 
# Figure 5 
# Remove duplicate rows of the data frame using cyl and vs variables 
boys<-distinct(dhs_b2, male_size_ht, .keep_all= TRUE) 
girls<-distinct(dhs_g2, female_size_ht, .keep_all= TRUE) 
# 
malesize = boys$male_size_ht 
femalesize = girls$female_size_ht 
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maleintensity = boys$male_velocity_ht*100 # expressing intensity as a % 
femaleintensity = girls$female_velocity_ht*100 # expressing intensity as a % 
par(mfrow=c(2,2))  
par(mar = c(4,4,1,1) + 0.1, cex = 0.8) 
hist(malesize,main="Size - Boys",xlab="Size relative to the WHO (cm)", 
     xlim=c(-8,0), col="blue",las=1,ylim=c(0,30),breaks=25) 
hist(femalesize,main="Size - Girls",xlab="Size relative to the WHO (cm)", 
     xlim=c(-8,0), col="red",las=1,ylim=c(0,30),breaks=25) 
hist(maleintensity,main="Intensity - Boys",xlab="Intensity relative to the WHO (%)", 
     xlim=c(-20,5), col="blue",las=1,ylim=c(0,30),breaks=25) 
hist(femaleintensity,main="Intensity - Girls",xlab="Intensity relative to the WHO (%)", 
     xlim=c(-20,5), col="red",las=1,ylim=c(0,30),breaks=25) 
 
# Stunting for boys 
boys = as.data.frame(boys ) 
Cor_Stunting_b<-cbind(boys$male_size_ht,boys$male_velocity_ht, boys$mean_HAZ, 
boys$Stunting) 
boys$Stunting = boys$Stunting*100 # converting stunting to a % 
Cor_Stunting_b = as.matrix(Cor_Stunting_b ) 
colnames(Cor_Stunting_b )<-c("Size: Male", "Intensity: Male", "Mean HAZ: Male", "Stunting 
(%): Male") 
 
stunting_cor_male = chart.Correlation(Cor_Stunting_b , histogram=FALSE, pch=19) 
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girls$Stunting = girls$Stunting*100 # coverting stunting to a % 
Cor_Stunting_g = as.matrix(Cor_Stunting_g) 
colnames(Cor_Stunting_g)<-c("Size: Female", "Intensity: Female", "Mean HAZ: Female", 
"Stunting (%): Female") 
 
stunting_cor_female = chart.Correlation(Cor_Stunting_g, histogram=FALSE, pch=19) 
 
# Figure 6A - Boys 
# Scatter plot with correlation coefficient 
# Male size and intensity 
p1 = ggscatter(boys, x = "male_velocity_ht", y = "male_size_ht", 
               add = "reg.line",  # Add regressin line 
               add.params = list(color = "blue", fill = "lightgray"), # Customize reg. line 
               conf.int = TRUE, # Add confidence interval 
               ylab="Size parameter (cm)", xlab="Intensity parameter (%)", 
               main="Boys", 
               cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
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# Male size and mean HAZ 
p3 = ggscatter(boys, x = "mean_HAZ", y = "male_size_ht", 
               add = "reg.line",  # Add regressin line 
               add.params = list(color = "blue", fill = "lightgray"), # Customize reg. line 
               conf.int = TRUE, # Add confidence interval 
               ylab="Size (cm)", xlab="Mean HAZ", 
               main="Boys", xlim=c(-3,1), ylim=c(-8,0), 
               cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
               cor.coeff.args = list(method = "pearson", label.x = -3, label.y = -0.5, label.sep = "\n")) 
 
# Male size and % Stunting 
p5 = ggscatter(boys, x = "Stunting", y = "male_size_ht", 
               add = "reg.line",  # Add regressin line 
               add.params = list(color = "blue", fill = "lightgray"), # Customize reg. line 
               conf.int = TRUE, # Add confidence interval 
               ylab="Size (cm)", xlab="Stunting (%)", 
               main="Boys",xlim=c(0,80), ylim=c(-8,0), 
               cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
               cor.coeff.args = list(method = "pearson", label.x = 0, label.y = -0.5, label.sep = "\n")) 
 
# Male intensity and mean HAZ 
p7 = ggscatter(boys, x = "mean_HAZ", y = "male_velocity_ht", 
               add = "reg.line",  # Add regressin line 
               add.params = list(color = "blue", fill = "lightgray"), # Customize reg. line 
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               conf.int = TRUE, # Add confidence interval 
               ylab="Intensity (%)", xlab="Mean HAZ", 
               main="Boys",xlim=c(-3,1), ylim=c(-0.3,0.1), 
               cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
               cor.coeff.args = list(method = "pearson", label.x = -3, label.y = 0.05, label.sep = "\n")) 
 
# Male intensity and mean HAZ 
p9 = ggscatter(boys, x = "Stunting", y = "male_velocity_ht", 
               add = "reg.line",  # Add regressin line 
               add.params = list(color = "blue", fill = "lightgray"), # Customize reg. line 
               conf.int = TRUE, # Add confidence interval 
               ylab="Intensity (%)", xlab="Stunting (%)", 
               main="Boys",xlim=c(0,80), ylim=c(-0.3,0.1), 
               cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
               cor.coeff.args = list(method = "pearson", label.x = 0, label.y = 0.08, label.sep = "\n")) 
 
plot_grid(p3, p5, p7, p9,labels = "AUTO") # combining plots 
 
# Figure 6B - Girls 
# Scatter plot with correlation coefficient 
# Female size and intensity 
p2 = ggscatter(girls, x = "female_velocity_ht", y = "female_size_ht", 
               add = "reg.line",  # Add regressin line 
               add.params = list(color = "red", fill = "lightgray"), # Customize reg. line 
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               conf.int = TRUE, # Add confidence interval 
               ylab="Size parameter (cm)", xlab="Intensity parameter (%)", 
               main="Girls", 
               cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
               cor.coeff.args = list(method = "pearson", label.x = -0.2, label.sep = "\n")) 
 
# Female size and mean HAZ 
p4 = ggscatter(girls, x = "mean_HAZ", y = "female_size_ht", 
               add = "reg.line",  # Add regressin line 
               add.params = list(color = "red", fill = "lightgray"), # Customize reg. line 
               conf.int = TRUE, # Add confidence interval 
               ylab="Size (cm)", xlab="Mean HAZ", 
               main="Girls", xlim=c(-3,1), ylim=c(-8,0), 
               cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
               cor.coeff.args = list(method = "pearson", label.x = -3, label.y = -0.5, label.sep = "\n")) 
 
# Female size and % Stunting 
p6 = ggscatter(girls, x = "Stunting", y = "female_size_ht", 
               add = "reg.line",  # Add regressin line 
               add.params = list(color = "red", fill = "lightgray"), # Customize reg. line 
               conf.int = TRUE, # Add confidence interval 
               ylab="Size (cm)", xlab="Stunting (%)", 
               main="Girls",xlim=c(0,80), ylim=c(-8,0), 
               cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
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               cor.coeff.args = list(method = "pearson", label.x = 0, label.y = -0.45, label.sep = "\n")) 
 
# Female intensity and mean HAZ 
p8 = ggscatter(girls, x = "mean_HAZ", y = "female_velocity_ht", 
               add = "reg.line",  # Add regressin line 
               add.params = list(color = "red", fill = "lightgray"), # Customize reg. line 
               conf.int = TRUE, # Add confidence interval 
               ylab="Intensity (%)", xlab="Mean HAZ", 
               main="Girls",xlim=c(-3,1), ylim=c(-0.3,0.1), 
               cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
               cor.coeff.args = list(method = "pearson", label.x = -3, label.y = 0.05, label.sep = "\n")) 
 
# Female intensity and mean HAZ 
p10 = ggscatter(girls, x = "Stunting", y = "female_velocity_ht", 
                add = "reg.line",  # Add regressin line 
                add.params = list(color = "red", fill = "lightgray"), # Customize reg. line 
                conf.int = TRUE, # Add confidence interval 
                ylab="Intensity (%)", xlab="Stunting (%)", 
                main="Girls",xlim=c(0,80), ylim=c(-0.3,0.1), 
                cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
                cor.coeff.args = list(method = "pearson", label.x = 0, label.y = 0.08, label.sep = "\n")) 
 
plot_grid(p4, p6, p8, p10,labels = "AUTO") # combining plots 
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# Male intensity and male size 
boys$male_velocity_ht = boys$male_velocity_ht*100 
girls$female_velocity_ht = girls$female_velocity_ht*100 
 
p11 = ggscatter(boys, y = "male_size_ht", x = "male_velocity_ht", 
                add = "reg.line",  # Add regressin line 
                add.params = list(color = "blue", fill = "lightgray"), # Customize reg. line 
                conf.int = TRUE, # Add confidence interval 
                xlab="Intensity (%)", ylab="Size (cm)", 
                main="Boys",xlim=c(-20,5), ylim=c(-8,0), 
                cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
                cor.coeff.args = list(method = "pearson", label.x = 0, label.y = 0.08, label.sep = "\n")) 
 
# Male intensity and male size 
p12 = ggscatter(girls, y = "female_size_ht", x = "female_velocity_ht", 
                add = "reg.line",  # Add regressin line 
                add.params = list(color = "blue", fill = "lightgray"), # Customize reg. line 
                conf.int = TRUE, # Add confidence interval 
                xlab="Intensity (%)", ylab="Size (cm)", 
                main="Girls",xlim=c(-20,5), ylim=c(-8,0), 
                cor.coef = TRUE, # Add correlation coefficient. see ?stat_cor 
                cor.coeff.args = list(method = "pearson", label.x = 0, label.y = 0.08, label.sep = "\n")) 
 
plot_grid(p11, p12,labels = "AUTO") # Better for combining plots 
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## Figure 7A 
## add extra space to right margin of plot within frame 
boys$year <- boys$year+1999 
girls$year <- girls$year+1999 
 
par(mfrow=c(2,2)) 
par(mar=c(5, 4, 4, 6) + 0.1) 
## Plot first set of data and draw its axis 
plot(male_size_ht ~year, data=boys, pch=16, axes=FALSE, ylim=c(-8,0),  
     xlim=c(2000,2020), xlab="", ylab="", subset = country == 50,  
     main="Boys: Peru",col="black") 
axis(2, ylim=c(-8,0),col="black",las=1)  ## las=1 makes horizontal labels 
axis(1, xlim=c(2000,2020),col="black",las=1)  ## las=1 makes horizontal labels 
mtext("Size (cm)",side=2,line=2.5) 
box() 
## Allow a second plot on the same graph 
par(new=TRUE) 
## Plot the second plot and put axis scale on right 
plot(mean_HAZ ~ year, pch=1, data=boys,  xlab="", ylab="",  
     ylim=c(-4,4), xlim=c(2000,2020), 
     axes=FALSE, col="black",subset = country == 50) 
## a little farther out (line=4) to make room for labels 
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mtext("Mean HAZ",side=4,col="black",line=4)  
axis(4, ylim=c(-4,4), col="black",col.axis="black",las=1) 
 
## Draw the time axis 
mtext("Survey year",side=1,col="black",line=2.5)   
box() 
## Add Legend 
legend("topleft",legend=c("Size parameter","Mean HAZ"), 
       text.col=c("black","black"),pch=c(16,1),col=c("black","black")) 
 
par(mar = c(5,4,4,6) + 0.1, cex = 0.8) 
## Plot first set of data and draw its axis 
plot(male_size_ht ~year, data=boys, pch=16, axes=FALSE, ylim=c(-8,0),  
     xlim=c(2000,2020), xlab="", ylab="", subset = country == 53,  
     main="Boys: Senegal",col="black") 
axis(2, ylim=c(-8,0),col="black",las=1)  ## las=1 makes horizontal labels 
axis(1, xlim=c(2000,2020),col="black",las=1)  ## las=1 makes horizontal labels 
mtext("Size (cm)",side=2,line=2.5) 
box() 
## Allow a second plot on the same graph 
par(new=TRUE) 
## Plot the second plot and put axis scale on right 
plot(mean_HAZ ~ year, pch=1, data=boys,  xlab="", ylab="",  
     ylim=c(-4,4), xlim=c(2000,2020), 
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     axes=FALSE, col="black",subset = country == 53) 
## a little farther out (line=4) to make room for labels 
mtext("Mean HAZ",side=4,col="black",line=4)  
axis(4, ylim=c(-4,4), col="black",col.axis="black",las=1) 
 
## Draw the time axis 
mtext("Survey year",side=1,col="black",line=2.5)   
#box() 
## Add Legend 
legend("topleft",legend=c("Size parameter","Mean HAZ"), 
       text.col=c("black","black"),pch=c(16,1),col=c("black","black")) 
 
par(mar = c(5,4,4,6) + 0.1, cex = 0.8) 
## Plot first set of data and draw its axis 
plot(female_size_ht ~year, data=girls, pch=16, axes=FALSE, ylim=c(-8,0),  
     xlim=c(2000,2020), xlab="", ylab="", subset = country == 19,  
     main="Girls: Egypt",col="black") 
axis(2, ylim=c(-8,0),col="black",las=1)  ## las=1 makes horizontal labels 
axis(1, xlim=c(2000,2020),col="black",las=1)  ## las=1 makes horizontal labels 
mtext("Size (cm)",side=2,line=2.5) 
box() 
## Allow a second plot on the same graph 
par(new=TRUE) 
## Plot the second plot and put axis scale on right 
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plot(mean_HAZ ~ year, pch=1, data=girls,  xlab="", ylab="",  
     ylim=c(-4,4), xlim=c(2000,2020), 
     axes=FALSE, col="black",subset = country == 19) 
## a little farther out (line=4) to make room for labels 
mtext("Mean HAZ",side=4,col="black",line=4)  
axis(4, ylim=c(-4,4), col="black",col.axis="black",las=1) 
 
## Draw the time axis 
mtext("Survey year",side=1,col="black",line=2.5)   
box() 
## Add Legend 
legend("topleft",legend=c("Size parameter","Mean HAZ"), 
       text.col=c("black","black"),pch=c(16,1),col=c("black","black")) 
 
par(mar=c(5, 4, 4, 6) + 0.1) 
## Plot first set of data and draw its axis 
plot(female_size_ht ~year, data=girls, pch=16, axes=FALSE, ylim=c(-8,0),  
     xlim=c(2000,2020), xlab="", ylab="", subset = country == 45,  
     main="Girls: Nepal",col="black") 
axis(2, ylim=c(-8,0),col="black",las=1)  ## las=1 makes horizontal labels 
axis(1, xlim=c(2000,2020),col="black",las=1)  ## las=1 makes horizontal labels 
mtext("Size (cm)",side=2,line=2.5) 
box() 
## Allow a second plot on the same graph 
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par(new=TRUE) 
## Plot the second plot and put axis scale on right 
plot(mean_HAZ ~ year, pch=1, data=girls,  xlab="", ylab="",  
     ylim=c(-4,4), xlim=c(2000,2020), 
     axes=FALSE, col="black",subset = country == 45) 
## a little farther out (line=4) to make room for labels 
mtext("Mean HAZ",side=4,col="black",line=4)  
axis(4, ylim=c(-4,4), col="black",col.axis="black",las=1) 
 
## Draw the time axis 
mtext("Survey year",side=1,col="black",line=2.5)   
box() 
## Add Legend 
legend("topleft",legend=c("Size parameter","Mean HAZ"), 




## Figure 7B 
 
## add extra space to right margin of plot within frame 
 
par(mfrow=c(2,2)) 
par(mar=c(5, 4, 4, 6) + 0.1) 
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## Plot first set of data and draw its axis 
plot(male_velocity_ht ~year, data=boys, pch=16, axes=FALSE, ylim=c(-10,0),  
     xlim=c(2000,2020), xlab="", ylab="", subset = country == 50,  
     main="Boys: Peru",col="black") 
axis(2, ylim=c(-10,0),col="black",las=1)  ## las=1 makes horizontal labels 
axis(1, xlim=c(2000,2020),col="black",las=1)  ## las=1 makes horizontal labels 
mtext("Intensity (%)",side=2,line=2.5) 
box() 
## Allow a second plot on the same graph 
par(new=TRUE) 
## Plot the second plot and put axis scale on right 
plot(mean_HAZ ~ year, pch=1, data=boys,  xlab="", ylab="",  
     ylim=c(-4,4), xlim=c(2000,2020), 
     axes=FALSE, col="black",subset = country == 50) 
## a little farther out (line=4) to make room for labels 
mtext("Mean HAZ",side=4,col="black",line=4)  
axis(4, ylim=c(-4,4), col="black",col.axis="black",las=1) 
 
## Draw the time axis 
mtext("Survey year",side=1,col="black",line=2.5)   
box() 
## Add Legend 
legend("topleft",legend=c("Intensity parameter","Mean HAZ"), 
       text.col=c("black","black"),pch=c(16,1),col=c("black","black")) 
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par(mar = c(5,4,4,6) + 0.1, cex = 0.8) 
## Plot first set of data and draw its axis 
plot(male_size_ht ~year, data=boys, pch=16, axes=FALSE, ylim=c(-10,0),  
     xlim=c(2000,2020), xlab="", ylab="", subset = country == 53,  
     main="Boys: Senegal",col="black") 
axis(2, ylim=c(-10,0),col="black",las=1)  ## las=1 makes horizontal labels 
axis(1, xlim=c(2000,2020),col="black",las=1)  ## las=1 makes horizontal labels 
mtext("Intensity (%)",side=2,line=2.5) 
box() 
## Allow a second plot on the same graph 
par(new=TRUE) 
## Plot the second plot and put axis scale on right 
plot(mean_HAZ ~ year, pch=1, data=boys,  xlab="", ylab="",  
     ylim=c(-4,4), xlim=c(2000,2020), 
     axes=FALSE, col="black",subset = country == 53) 
## a little farther out (line=4) to make room for labels 
mtext("Mean HAZ",side=4,col="black",line=4)  
axis(4, ylim=c(-4,4), col="black",col.axis="black",las=1) 
 
## Draw the time axis 
mtext("Survey year",side=1,col="black",line=2.5)   
#box() 
## Add Legend 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Global Health
 doi: 10.1136/bmjgh-2020-004107:e004107. 6 2021;BMJ Global Health, et al. Ohuma EO
 27 
legend("topleft",legend=c("Intensity parameter","Mean HAZ"), 
       text.col=c("black","black"),pch=c(16,1),col=c("black","black")) 
 
par(mar = c(5,4,4,6) + 0.1, cex = 0.8) 
## Plot first set of data and draw its axis 
plot(female_size_ht ~year, data=girls, pch=16, axes=FALSE, ylim=c(-10,0),  
     xlim=c(2000,2020), xlab="", ylab="", subset = country == 19,  
     main="Girls: Egypt",col="black") 
axis(2, ylim=c(-10,0),col="black",las=1)  ## las=1 makes horizontal labels 
axis(1, xlim=c(2000,2020),col="black",las=1)  ## las=1 makes horizontal labels 
mtext("Intensity (%)",side=2,line=2.5) 
box() 
## Allow a second plot on the same graph 
par(new=TRUE) 
## Plot the second plot and put axis scale on right 
plot(mean_HAZ ~ year, pch=1, data=girls,  xlab="", ylab="",  
     ylim=c(-4,4), xlim=c(2000,2020), 
     axes=FALSE, col="black",subset = country == 19) 
## a little farther out (line=4) to make room for labels 
mtext("Mean HAZ",side=4,col="black",line=4)  
axis(4, ylim=c(-4,4), col="black",col.axis="black",las=1) 
 
## Draw the time axis 
mtext("Survey year",side=1,col="black",line=2.5)   
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box() 
## Add Legend 
legend("topleft",legend=c("Intensity parameter","Mean HAZ"), 
       text.col=c("black","black"),pch=c(16,1),col=c("black","black")) 
 
par(mar=c(5, 4, 4, 6) + 0.1) 
## Plot first set of data and draw its axis 
plot(female_size_ht ~year, data=girls, pch=16, axes=FALSE, ylim=c(-10,0),  
     xlim=c(2000,2020), xlab="", ylab="", subset = country == 45,  
     main="Girls: Nepal",col="black") 
axis(2, ylim=c(-10,0),col="black",las=1)  ## las=1 makes horizontal labels 
axis(1, xlim=c(2000,2020),col="black",las=1)  ## las=1 makes horizontal labels 
mtext("Intensity (%)",side=2,line=2.5) 
box() 
## Allow a second plot on the same graph 
par(new=TRUE) 
## Plot the second plot and put axis scale on right 
plot(mean_HAZ ~ year, pch=1, data=girls,  xlab="", ylab="",  
     ylim=c(-4,4), xlim=c(2000,2020), 
     axes=FALSE, col="black",subset = country == 45) 
## a little farther out (line=4) to make room for labels 
mtext("Mean HAZ",side=4,col="black",line=4)  
axis(4, ylim=c(-4,4), col="black",col.axis="black",las=1) 
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## Draw the time axis 
mtext("Survey year",side=1,col="black",line=2.5)   
box() 
## Add Legend 
legend("topleft",legend=c("Intensity parameter","Mean HAZ"), 




# Effect of size on SITAR parameters 
## BOYS 
size_birth = subset(dhs_b, ageint_mths==2) 
size_birth = merge(size_birth, boys, by="id") 
cor(size_birth$height,size_birth$male_size_ht) # 0.41 
cor(size_birth$height,size_birth$male_velocity_ht) # 0.14 
cor(size_birth$male_size_ht,size_birth$male_velocity_ht) # 0.91 






lm2 <- lm(size_birth$male_velocity_ht ~ size_birth$height, data=size_birth)   
print(lm2) 
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lm4 <- lm(size_birth$male_size_ht ~ size_birth$height + size_birth$male_velocity_ht, 




BIC(lm1, lm2, lm3, lm4) # BIC for each model 
 
## GIRLS 
size_birth = subset(dhs_g, ageint_mths==2) 
size_birth = merge(size_birth, girls, by="id") 
cor(size_birth$height,size_birth$female_size_ht) # 0.43 
cor(size_birth$height,size_birth$female_velocity_ht) # 0.14 
cor(size_birth$female_size_ht,size_birth$female_velocity_ht) # 0.89 
lf1 <- lm(size_birth$female_size_ht ~ size_birth$height, data=size_birth)   
print(lf1) 
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lf4 <- lm(size_birth$female_size_ht ~ size_birth$height + size_birth$female_velocity_ht, 




BIC(lf1, lf2, lf3, lf4) # BIC for each model 
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Supplementary File 3: Summary of 145 Demographic Health Surveys 
used for analyses 
 
country year Total sample % Boys 
Median age in 
months (IQR) 
Albania 2009 1,473 49.8% 33.5 (18.4 - 48.2) 
Albania 2017 2,610 51.0% 29.7 (14.7 - 44.9) 
Angola 2015 7,513 49.9% 28.9 (13.6 - 43.6) 
Armenia 2005 1,290 54.4% 27.4 (13.9 - 42.6) 
Armenia 2010 1,390 52.2% 27.7 (14.2 - 43) 
Armenia 2016 1,593 52.9% 29 (15.1 - 44.4) 
Azerbaijan 2006 2,049 53.4% 27.1 (13.4 - 42.9) 
Bangladesh 2004 6,102 50.6% 28.9 (14.4 - 43.9) 
Bangladesh 2007 5,473 49.6% 29.3 (15.2 - 44.1) 
Bangladesh 2011 7,920 50.6% 31.8 (14.8 - 45.9) 
Bangladesh 2014 7,235 52.0% 29.5 (14.3 - 44.7) 
Benin 2001 4,098 49.8% 25.8 (11.5 - 40.9) 
Benin 2006 13,520 50.0% 27.8 (12.8 - 42.4) 
Benin 2012 9,367 50.0% 30.6 (15.6 - 45) 
Bolivia 2003 9,823 51.4% 31.3 (15.6 - 46.1) 
Bolivia 2008 8,395 50.7% 29.8 (14.9 - 44.9) 
Burkina Faso 2003 8,882 51.1% 28.5 (12.7 - 43.2) 
Burkina Faso 2010 6,960 51.0% 28.6 (13.9 - 43.7) 
Burundi 2010 3,612 51.2% 28.2 (14.5 - 43.4) 
Burundi 2016 6,358 50.3% 29.9 (14.6 - 45.5) 
Cambodia 2000 3,753 51.4% 31 (14 - 45.5) 
Cambodia 2005 3,853 48.4% 29.6 (15 - 44.6) 
Cambodia 2010 4,103 51.5% 30.1 (15.1 - 45.2) 
Cambodia 2014 4,938 50.9% 29.2 (15.2 - 44.2) 
Cameroon 2004 3,756 50.0% 27.5 (13.5 - 44.6) 
Cameroon 2011 5,882 48.8% 28.1 (13.5 - 43.4) 
Chad 2015 10,760 50.0% 30.6 (13.9 - 45.3) 
Colombia 2010 17,749 51.4% 30.6 (15.4 - 45.2) 
Comoros 2012 2,883 50.1% 29.3 (14.4 - 43.4) 
Congo Brazzaville 2005 4,418 50.8% 27.6 (13.3 - 42.4) 
Congo Brazzaville 2011 4,965 49.6% 28.3 (13.3 - 42) 
Congo, DRC 2007 3,717 48.8% 29.1 (14.7 - 44.7) 
Congo, DRC 2013 9,031 50.2% 29.2 (13.7 - 44.2) 
Ivory coast 2012 3,788 49.0% 28.2 (13.3 - 42.6) 
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Dominican Republic 2002 11,017 50.7% 29.9 (15.7 - 44.9) 
Dominican Republic 2007 11,084 52.1% 31.5 (16.5 - 45.9) 
Dominican Republic 2013 3,678 51.1% 31.1 (15.7 - 45.8) 
Egypt 2000 10,692 51.5% 28.5 (13.8 - 43.2) 
Egypt 2003 6,213 52.1% 29 (14.7 - 44.3) 
Egypt 2005 12,907 50.6% 29.8 (15 - 44.5) 
Egypt 2008 10,112 50.5% 27.7 (13.3 - 43.5) 
Egypt 2014 14,717 52.2% 28.8 (14.3 - 43.4) 
Eritrea 2002 5,627 50.9% 30.6 (13.6 - 46.1) 
Ethiopia 2000 9,326 50.2% 29.8 (14.7 - 43.9) 
Ethiopia 2005 4,221 50.1% 31.1 (14.7 - 45.4) 
Ethiopia 2011 10,400 51.2% 31.5 (14.4 - 45.1) 
Ethiopia 2016 9,471 51.1% 29.7 (14 - 45.5) 
Gabon 2012 4,155 51.2% 29.5 (13.1 - 43.3) 
Gambia 2013 3,598 51.2% 27.5 (12.7 - 42.2) 
Ghana 2008 2,714 51.1% 29.9 (15.1 - 45.4) 
Ghana 2014 3,049 52.5% 29.3 (14.5 - 43.5) 
Guatemala 2015 12,286 51.7% 29.9 (14.8 - 44.6) 
Guinea 2012 3,572 51.5% 28.9 (14.1 - 43.4) 
Guyana 2009 1,823 49.8% 29.7 (15.9 - 44.9) 
Haiti 2000 6,436 49.5% 29.3 (15.5 - 43.8) 
Haiti 2006 2,974 48.8% 29.7 (14.7 - 43.7) 
Haiti 2012 4,742 51.6% 27.8 (13.5 - 43.5) 
Haiti 2017 6,769 49.8% 30.9 (15.4 - 46.1) 
Honduras 2006 10,275 51.1% 31.5 (17 - 46) 
Honduras 2012 10,943 52.3% 28.6 (14.2 - 44) 
India 2006 43,728 52.3% 30.1 (15.3 - 44.8) 
India 2015 239,588 52.0% 30.2 (15.3 - 44.6) 
Jordan 2002 4,990 50.1% 28.7 (13.8 - 44.3) 
Jordan 2007 4,648 50.0% 30.1 (15.4 - 45.3) 
Jordan 2009 4,444 51.9% 28 (14.4 - 43) 
Jordan 2012 6,412 51.5% 31.3 (16 - 45.2) 
Kenya 2003 5,157 50.3% 28.6 (13.2 - 43.7) 
Kenya 2009 5,684 51.1% 29.5 (14.9 - 44.5) 
Kenya 2014 20,668 50.9% 30 (15 - 44.5) 
Kyrgyzstan 2012 4,618 51.7% 27.7 (13.8 - 42.9) 
Lesotho 2009 2,235 49.5% 29.5 (14.7 - 45.4) 
Lesotho 2014 1,907 48.1% 30.8 (15.4 - 44.7) 
Liberia 2007 5,329 51.8% 30.2 (14.8 - 45) 
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Liberia 2013 3,867 53.8% 29.9 (14.2 - 45.1) 
Madagascar 2004 5,043 48.9% 28.6 (13.8 - 44.2) 
Madagascar 2009 5,841 50.0% 31.2 (15.3 - 45.8) 
Malawi 2000 10,226 49.2% 27.5 (12.9 - 42.4) 
Malawi 2004 9,098 49.4% 27.9 (13.4 - 43.8) 
Malawi 2010 5,007 48.6% 29.3 (15.4 - 44.3) 
Malawi 2015 5,686 48.6% 30.8 (15.3 - 45.4) 
Maldives 2009 2,636 50.6% 28.7 (13.3 - 44) 
Mali 2001 10,427 50.6% 27.5 (12 - 43.3) 
Mali 2006 12,062 50.6% 27.2 (13 - 42.5) 
Mali 2012 4,951 51.4% 31.6 (16.9 - 45.2) 
Moldova 2005 1,506 50.9% 29.6 (15.3 - 43.9) 
Morocco 2003 5,694 49.7% 30 (14.9 - 44.9) 
Mozambique 2003 9,103 49.3% 28.5 (13.3 - 43.2) 
Mozambique 2011 10,411 49.9% 28.3 (13.3 - 43.2) 
Myanmar 2016 4,648 51.7% 30 (15 - 45) 
Namibia 2000 4,023 49.7% 28.6 (14.2 - 44.2) 
Namibia 2007 5,167 49.9% 29 (14 - 43.7) 
Namibia 2013 2,617 49.2% 28.7 (14.6 - 44.1) 
Nepal 2001 6,389 49.0% 29.6 (14.6 - 44.3) 
Nepal 2006 5,450 51.5% 30.8 (15.9 - 45.3) 
Nepal 2011 2,441 51.3% 30.3 (15 - 44.1) 
Nepal 2016 2,446 52.0% 29.9 (15.7 - 44.9) 
Nicaragua 2001 6,650 51.0% 29.8 (15.7 - 44.4) 
Niger 2006 4,043 51.5% 27.6 (12.6 - 42.9) 
Niger 2012 5,310 50.2% 28.4 (13.1 - 43.5) 
Nigeria 2003 4,824 49.9% 26.7 (11.9 - 41.9) 
Nigeria 2008 22,394 50.1% 28.6 (13.3 - 43.2) 
Nigeria 2013 27,358 50.1% 29 (13.6 - 44.3) 
Pakistan 2012 3,316 50.1% 29.5 (14.1 - 44.7) 
Pakistan 2018 4,211 51.2% 29 (14.4 - 43.7) 
Peru 2005 2,454 51.1% 29.4 (14.3 - 45.1) 
Peru 2008 8,554 50.2% 31 (16 - 45.6) 
Peru 2009 9,814 51.4% 30.8 (14.6 - 46.1) 
Peru 2010 9,249 50.4% 30.2 (15.7 - 45.5) 
Peru 2011 9,193 50.8% 30.2 (15.6 - 44.8) 
Peru 2012 9,675 50.9% 30.8 (15.5 - 45.1) 
Rwanda 2000 6,681 49.6% 28.6 (12 - 44.6) 
Rwanda 2005 3,936 49.0% 27.9 (13.4 - 41.8) 
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Rwanda 2010 4,368 50.2% 31.1 (16.3 - 45.3) 
Rwanda 2015 3,810 50.5% 29.3 (14.3 - 43) 
Sao Tome and 
Principe 2008 1,831 49.9% 30 (16.3 - 43.3) 
Senegal 2005 3,179 51.1% 27.6 (13.4 - 42.3) 
Senegal 2010 4,005 51.5% 27.9 (13.5 - 42.8) 
Senegal 2013 6,550 50.0% 28.7 (13.9 - 43.1) 
Senegal 2014 6,762 51.1% 29.4 (15.4 - 44.4) 
Senegal 2015 6,885 50.2% 29.9 (15.1 - 44.4) 
Senegal 2016 6,699 51.3% 30.5 (15.2 - 44.5) 
Senegal 2017 11,919 51.3% 30.4 (15.3 - 45.2) 
Sierra Leone 2008 2,794 48.8% 28.6 (14.1 - 44.3) 
Sierra Leone 2013 5,367 48.6% 30.8 (15.3 - 44.5) 
South Africa 2016 1,468 50.8% 31.3 (16 - 46.1) 
Swaziland 2006 2,815 49.5% 30.1 (15 - 45.3) 
Tajikistan 2012 4,781 50.9% 27.7 (14 - 42.4) 
Tajikistan 2017 6,038 50.3% 29.4 (15.3 - 44.6) 
Tanzania 2004 7,938 49.9% 28 (13.6 - 43.5) 
Tanzania 2010 7,632 49.5% 28.9 (14.2 - 44.3) 
Tanzania 2015 10,184 50.5% 29 (14.8 - 44.4) 
Timor-Leste 2009 8,452 50.5% 31.2 (16.4 - 44.8) 
Timor-Leste 2016 6,661 51.4% 31.2 (16.6 - 45.1) 
Togo 2014 3,535 50.4% 29.6 (14.9 - 44.4) 
Uganda 2000 5,693 49.8% 27.1 (13.8 - 43) 
Uganda 2006 2,661 50.6% 28.6 (13.8 - 43.4) 
Uganda 2011 2,360 49.7% 28.6 (14 - 43.6) 
Uganda 2016 5,160 50.2% 29.9 (15.6 - 44.9) 
Yemen 2013 14,344 50.9% 27.9 (13.6 - 43.5) 
Zambia 2002 5,985 49.8% 28 (13.8 - 43.5) 
Zambia 2007 5,715 49.4% 28.3 (14.3 - 43.7) 
Zambia 2013 12,627 50.3% 30.3 (15.4 - 45.4) 
Zimbabwe 2005 5,061 50.0% 31 (15.3 - 45.8) 
Zimbabwe 2010 5,359 49.5% 27.5 (12.3 - 42.3) 
Zimbabwe 2015 6,084 49.6% 31.8 (16.7 - 46.3) 
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Supplementary File 4: Goodness of fit plots after SITAR modelling. For 
illustration, we show crude height data for boy’s height in Egypt in 2014 
(open circles, top-left panel), girls in Peru in 2012 (open circles, top-right 
panel), WHO child height standards for boys (open circles, bottom-left 
panel), and WHO child height standards for girls (open circles, bottom-
right panel). The corresponding SITAR fitted growth curves are shown in 
solid blue line and the fitted SITAR population-mean curves are shown 
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Supplementary File 5: Table of the SITAR random effects for size and 
intensity parameters with and without inclusion of the mean height of 






Without WHO data included 
 
With WHO data included 
 
  Female Male Female Male  
Country Survey 
year Size Intensity Size Intensity Size Intensity Size Intensity  
 
 
Albania 2009 1.811 0.076 2.216 0.091 1.780 0.075 2.184 0.090  
Albania 2017 2.739 0.086 3.355 0.085 2.713 0.085 3.332 0.083  
Angola 2015 -0.507 0.020 -0.504 -0.010 -0.545 0.019 -0.543 -0.011  
Armenia 2005 2.605 0.125 3.344 0.100 2.575 0.124 3.319 0.099  
Armenia 2010 1.687 0.034 1.559 0.057 1.659 0.033 1.526 0.056  
Armenia 2016 3.965 0.129 3.753 0.122 3.942 0.128 3.728 0.120  
Azerbaijan 2006 0.229 -0.039 0.290 -0.008 0.199 -0.040 0.257 -0.009  
Bangladesh 2004 -2.098 -0.050 -1.758 -0.044 -2.139 -0.050 -1.802 -0.044  
Bangladesh 2007 -1.420 -0.046 -0.900 -0.034 -1.459 -0.046 -0.939 -0.034  
Bangladesh 2011 -1.152 -0.033 -0.766 -0.009 -1.190 -0.034 -0.807 -0.010  
Bangladesh 2014 -0.794 -0.033 -0.355 -0.007 -0.830 -0.034 -0.393 -0.008  
Benin 2001 -0.417 -0.025 -0.366 -0.038 -0.452 -0.026 -0.400 -0.039  
Benin 2006 -1.649 -0.053 -1.904 -0.049 -1.688 -0.053 -1.949 -0.049  
Benin 2012 -2.242 -0.083 -2.648 -0.062 -2.282 -0.083 -2.697 -0.062  
Bolivia 2003 -0.201 -0.005 0.042 0.008 -0.237 -0.006 0.004 0.007  
Bolivia 2008 0.289 0.002 0.588 0.015 0.255 0.002 0.554 0.015  
Burkina Faso 2003 -1.123 -0.072 -1.420 -0.074 -1.158 -0.073 -1.457 -0.074  
Burkina Faso 2010 -0.281 -0.012 -0.270 -0.006 -0.316 -0.012 -0.308 -0.007  
Burundi 2010 -2.378 -0.055 -2.583 -0.071 -2.421 -0.055 -2.630 -0.071  
Burundi 2016 -2.309 -0.049 -2.473 -0.061 -2.352 -0.050 -2.520 -0.061  
Cambodia 2000 -1.781 -0.070 -1.424 -0.055 -1.820 -0.071 -1.464 -0.055  
Cambodia 2005 -1.301 -0.044 -1.182 -0.051 -1.339 -0.045 -1.221 -0.051  
Cambodia 2010 -1.052 -0.053 -0.667 -0.054 -1.089 -0.053 -0.702 -0.055  
Cambodia 2014 -0.257 -0.025 -0.018 -0.011 -0.292 -0.026 -0.053 -0.012  
Cameroon 2004 -0.258 0.004 -0.012 0.012 -0.294 0.003 -0.050 0.011  
Cameroon 2011 0.187 -0.018 0.092 -0.013 0.155 -0.019 0.058 -0.014  
Chad 2015 -0.551 -0.049 -0.665 -0.066 -0.585 -0.050 -0.697 -0.067  
Colombia 2010 1.650 0.076 1.876 0.068 1.618 0.075 1.845 0.067  
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Without WHO data included 
 
With WHO data included 
 
  Female Male Female Male  
Country Survey 
year Size Intensity Size Intensity Size Intensity Size Intensity  
 
 
Comoros 2012 0.362 0.007 0.162 0.018 0.329 0.006 0.125 0.018  
Congo 
Brazzaville 2005 0.943 0.000 0.482 0.009 0.914 -0.001 0.448 0.008  
Congo 
Brazzaville 2011 0.808 0.040 1.101 0.041 0.774 0.039 1.068 0.040  
Congo, DRC 2007 -1.499 -0.087 -2.667 -0.099 -1.535 -0.088 -2.710 -0.100  
Congo, DRC 2013 -0.839 -0.077 -1.042 -0.065 -0.873 -0.078 -1.078 -0.066  
Ivory Coast 2012 0.555 -0.007 0.436 -0.006 0.524 -0.008 0.404 -0.008  
Dominican 
Republic 2002 2.800 0.101 2.909 0.101 2.773 0.100 2.880 0.100  
Dominican 
Republic 2007 3.013 0.091 3.134 0.094 2.987 0.089 3.109 0.093  
Dominican 
Republic 2013 3.150 0.124 3.169 0.120 3.122 0.123 3.140 0.118  
Egypt 2000 0.828 0.069 0.798 0.061 0.793 0.069 0.759 0.060  
Egypt 2003 1.035 0.070 0.778 0.090 1.001 0.069 0.734 0.089  
Egypt 2005 1.380 0.067 1.333 0.075 1.348 0.066 1.296 0.074  
Egypt 2008 0.918 0.018 0.567 0.017 0.887 0.017 0.533 0.016  
Egypt 2014 2.738 0.063 2.828 0.077 2.713 0.062 2.803 0.076  
Eritrea 2002 -1.359 -0.049 -1.145 -0.052 -1.397 -0.050 -1.183 -0.052  
Ethiopia 2000 -2.820 -0.100 -2.707 -0.083 -2.861 -0.101 -2.753 -0.083  
Ethiopia 2005 -2.105 -0.083 -2.157 -0.088 -2.145 -0.083 -2.198 -0.088  
Ethiopia 2011 -1.047 -0.060 -1.058 -0.060 -1.083 -0.061 -1.094 -0.061  
Ethiopia 2016 -0.329 -0.014 -0.469 -0.038 -0.364 -0.015 -0.504 -0.039  
Gabon 2012 1.850 0.072 1.777 0.068 1.820 0.071 1.745 0.067  
Gambia 2013 1.257 0.031 1.761 0.053 1.227 0.030 1.731 0.052  
Ghana 2008 0.473 -0.011 0.623 -0.006 0.441 -0.012 0.592 -0.008  
Ghana 2014 1.218 0.033 1.393 0.033 1.187 0.032 1.362 0.032  
Guatemala 2015 -1.621 -0.005 -1.305 0.008 -1.664 -0.005 -1.353 0.008  
Guinea 2012 0.695 -0.005 0.830 -0.015 0.665 -0.007 0.802 -0.016  
Guyana 2009 0.869 0.101 0.941 0.112 0.832 0.100 0.895 0.112  
Haiti 2000 0.818 0.018 0.336 0.012 0.787 0.017 0.300 0.011  
Haiti 2006 0.159 0.034 0.029 0.009 0.123 0.034 -0.008 0.008  
Haiti 2012 1.073 0.038 1.289 0.029 1.042 0.037 1.258 0.027  
Haiti 2017 1.324 0.059 1.190 0.053 1.292 0.058 1.156 0.052  
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Without WHO data included 
 
With WHO data included 
 
  Female Male Female Male  
Country Survey 
year Size Intensity Size Intensity Size Intensity Size Intensity  
 
 
Honduras 2006 0.347 -0.005 0.589 -0.014 0.315 -0.006 0.559 -0.015  
Honduras 2012 0.739 0.021 0.841 0.027 0.707 0.020 0.807 0.026  
India 2006 -1.840 -0.044 -1.344 -0.031 -1.880 -0.044 -1.386 -0.031  
India 2015 -0.237 -0.025 -0.038 -0.013 -0.271 -0.026 -0.073 -0.014  
Jordan 2002 1.923 0.077 2.493 0.077 1.893 0.076 2.465 0.076  
Jordan 2007 2.409 0.034 2.382 0.032 2.384 0.033 2.359 0.030  
Jordan 2009 2.780 0.068 3.142 0.053 2.755 0.066 3.122 0.051  
Jordan 2012 2.920 0.096 3.012 0.085 2.894 0.095 2.987 0.084  
Kenya 2003 0.203 0.007 -0.291 0.005 0.169 0.006 -0.331 0.005  
Kenya 2009 -0.166 0.010 -0.047 0.005 -0.202 0.009 -0.085 0.004  
Kenya 2014 0.964 0.042 0.582 0.025 0.931 0.041 0.546 0.024  
Kyrgyzstan 2012 1.735 0.024 1.676 0.034 1.707 0.023 1.647 0.032  
Lesotho 2009 0.041 -0.025 -0.408 -0.040 0.008 -0.026 -0.442 -0.041  
Lesotho 2014 0.072 0.011 -0.820 0.013 0.037 0.010 -0.865 0.013  
Liberia 2007 -0.432 -0.080 -0.935 -0.056 -0.463 -0.081 -0.971 -0.057  
Liberia 2013 0.485 -0.029 0.101 -0.038 0.455 -0.031 0.071 -0.039  
Madagascar 2004 -1.909 -0.062 -2.214 -0.061 -1.949 -0.062 -2.259 -0.061  
Madagascar 2009 -1.375 -0.058 -1.491 -0.066 -1.413 -0.058 -1.530 -0.067  
Malawi 2000 -2.511 -0.086 -2.628 -0.084 -2.552 -0.086 -2.673 -0.084  
Malawi 2004 -2.068 -0.077 -2.393 -0.063 -2.107 -0.077 -2.440 -0.063  
Malawi 2010 -1.068 -0.014 -1.517 -0.025 -1.107 -0.014 -1.562 -0.025  
Malawi 2015 -0.310 -0.022 -0.332 -0.024 -0.345 -0.022 -0.368 -0.024  
Maldives 2009 1.205 0.069 1.359 0.099 1.172 0.068 1.319 0.099  
Mali 2001 -1.199 -0.050 -1.119 -0.061 -1.236 -0.051 -1.155 -0.062  
Mali 2006 -0.407 -0.027 -0.342 -0.023 -0.442 -0.028 -0.378 -0.023  
Mali 2012 0.200 -0.065 -0.105 -0.048 0.171 -0.066 -0.135 -0.050  
Moldova 2005 3.434 0.058 3.703 0.085 3.412 0.057 3.682 0.083  
Morocco 2003 1.701 0.049 1.575 0.027 1.672 0.048 1.547 0.026  
Mozambique 2003 -1.671 -0.032 -1.851 -0.037 -1.712 -0.032 -1.897 -0.038  
Mozambique 2011 -1.042 0.000 -1.211 0.003 -1.081 -0.001 -1.257 0.003  
Myanmar 2016 0.000 -0.017 -0.042 -0.004 -0.033 -0.018 -0.078 -0.005  
Namibia 2000 0.410 0.030 0.356 0.007 0.375 0.029 0.322 0.006  
Namibia 2007 0.368 0.024 0.216 0.011 0.334 0.023 0.179 0.011  
Namibia 2013 1.297 0.037 0.927 0.012 1.267 0.036 0.896 0.011  
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Without WHO data included 
 
With WHO data included 
 
  Female Male Female Male  
Country Survey 
year Size Intensity Size Intensity Size Intensity Size Intensity  
 
 
Nepal 2001 -2.730 -0.079 -2.091 -0.071 -2.772 -0.080 -2.134 -0.071  
Nepal 2006 -1.911 -0.063 -1.343 -0.059 -1.951 -0.064 -1.381 -0.060  
Nepal 2011 -1.236 -0.065 -0.599 -0.036 -1.272 -0.065 -0.635 -0.037  
Nepal 2016 -0.525 -0.027 -0.129 -0.018 -0.560 -0.028 -0.164 -0.019  
Nicaragua 2001 0.603 0.006 0.666 0.012 0.571 0.005 0.633 0.011  
Niger 2006 -2.899 -0.103 -3.034 -0.098 -2.941 -0.103 -3.080 -0.098  
Niger 2012 -1.151 -0.030 -1.234 -0.033 -1.189 -0.031 -1.275 -0.033  
Nigeria 2003 -1.069 -0.029 -1.538 -0.052 -1.107 -0.030 -1.579 -0.052  
Nigeria 2008 -1.247 -0.026 -1.783 -0.026 -1.286 -0.026 -1.830 -0.026  
Nigeria 2013 -0.269 -0.032 -0.449 -0.045 -0.302 -0.033 -0.482 -0.046  
Pakistan 2012 -2.422 -0.061 -2.483 -0.049 -2.464 -0.061 -2.532 -0.048  
Pakistan 2018 -0.939 -0.028 -0.593 -0.041 -0.976 -0.028 -0.628 -0.041  
Peru 2005 0.094 0.008 0.164 0.016 0.059 0.008 0.126 0.016  
Peru 2008 0.241 0.036 0.481 0.035 0.205 0.035 0.443 0.035  
Peru 2009 0.561 0.043 0.727 0.046 0.526 0.042 0.689 0.045  
Peru 2010 0.483 0.051 0.781 0.061 0.447 0.050 0.742 0.060  
Peru 2011 0.812 0.062 1.057 0.065 0.778 0.061 1.020 0.064  
Peru 2012 0.823 0.066 1.281 0.065 0.788 0.065 1.245 0.064  
Rwanda 2000 -1.156 -0.057 -1.328 -0.086 -1.193 -0.058 -1.363 -0.086  
Rwanda 2005 -1.993 -0.061 -1.976 -0.062 -2.034 -0.062 -2.019 -0.062  
Rwanda 2010 -1.084 -0.039 -1.086 -0.032 -1.121 -0.040 -1.126 -0.032  
Rwanda 2015 -0.530 -0.012 -0.873 -0.013 -0.566 -0.013 -0.915 -0.014  
Sao Tome 2008 0.371 0.065 0.082 0.067 0.334 0.064 0.036 0.067  
Senegal 2005 1.269 0.012 1.545 0.019 1.240 0.011 1.518 0.018  
Senegal 2010 0.944 0.020 0.670 0.001 0.913 0.019 0.638 0.000  
Senegal 2013 1.483 0.032 1.371 0.040 1.454 0.031 1.339 0.039  
Senegal 2014 1.432 0.040 1.466 0.056 1.402 0.039 1.433 0.056  
Senegal 2015 0.980 0.048 1.322 0.040 0.947 0.048 1.290 0.039  
Senegal 2016 1.482 0.076 1.501 0.071 1.449 0.075 1.466 0.070  
Senegal 2017 1.563 0.062 1.737 0.059 1.532 0.061 1.705 0.058  
Sierra Leone 2008 0.270 -0.037 -0.276 0.002 0.239 -0.038 -0.315 0.002  
Sierra Leone 2013 -0.739 -0.010 -0.465 0.008 -0.776 -0.011 -0.506 0.007  
South Africa 2016 0.668 0.065 0.946 0.048 0.632 0.064 0.910 0.047  
Swaziland 2006 0.395 0.020 0.120 0.023 0.361 0.019 0.082 0.023  
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Without WHO data included 
 
With WHO data included 
 
  Female Male Female Male  
Country Survey 
year Size Intensity Size Intensity Size Intensity Size Intensity  
 
 
Tajikistan 2012 0.092 -0.001 0.718 0.007 0.058 -0.002 0.686 0.006  
Tajikistan 2017 1.572 0.011 1.805 0.022 1.545 0.010 1.780 0.020  
Tanzania 2004 -1.364 -0.035 -1.348 -0.029 -1.403 -0.036 -1.391 -0.029  
Tanzania 2010 -0.991 -0.001 -1.193 -0.035 -1.030 -0.002 -1.234 -0.035  
Tanzania 2015 -0.279 0.002 -0.256 -0.008 -0.315 0.001 -0.293 -0.008  
Timor-Leste 2009 -2.275 -0.084 -2.471 -0.076 -2.315 -0.084 -2.516 -0.076  
Timor-Leste 2016 -0.460 -0.026 -0.567 -0.021 -0.495 -0.027 -0.606 -0.022  
Togo 2014 0.435 -0.006 0.500 0.006 0.403 -0.007 0.466 0.005  
Uganda 2000 -1.315 -0.019 -1.286 -0.038 -1.355 -0.020 -1.327 -0.039  
Uganda 2006 -0.199 -0.012 -0.564 -0.024 -0.234 -0.013 -0.601 -0.024  
Uganda 2011 0.004 0.023 -0.321 -0.011 -0.032 0.023 -0.359 -0.012  
Uganda 2016 0.711 0.040 0.585 0.016 0.678 0.039 0.550 0.015  
Yemen 2013 -1.929 -0.070 -1.690 -0.077 -1.969 -0.071 -1.729 -0.078  
Zambia 2002 -2.167 -0.062 -2.130 -0.068 -2.208 -0.063 -2.174 -0.069  
Zambia 2007 -0.980 -0.022 -1.427 -0.034 -1.018 -0.023 -1.469 -0.035  
Zambia 2013 -0.509 0.002 -0.680 0.003 -0.546 0.001 -0.722 0.003  
Zimbabwe 2005 -0.317 0.013 -0.766 -0.002 -0.354 0.013 -0.809 -0.003  
Zimbabwe 2010 -0.135 0.023 -0.368 0.001 -0.172 0.023 -0.408 0.001  
Zimbabwe 2015 0.498 0.053 0.478 0.037 0.462 0.052 0.440 0.037  
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Supplementary File 6: Scatter plot of the differences in the SITAR 
random effects for size and intensity parameters with versus without 
inclusion of the mean height of the WHO child growth standards in the 
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Supplementary File 7: Scatter plot, correlation, and line of best fit (95% 
CI; shaded region) between SITAR size and intensity random effects 
(excluding WHO) for 145 Demographic and Health surveys from 64 
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Supplementary File 8: Scatter plot, correlation, and line of best fit (95% 
CI; shaded region)  between SITAR size and intensity random effects 
(excluding WHO) with stunting prevalence and mean height-for-age z-
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Supplementary File 9: Scatter plot, correlation, and line of best fit (95% 
CI; shaded region)  between SITAR size and intensity random effects 
(excluding WHO) with stunting prevalence and mean height-for-age z-
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Supplementary File 10: Sensitivity analysis comparing the mean 
population growth curve using all surveys (n=145 surveys) compared to 
using only the latest survey in each country (n=64 countries): Boys (left 





BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Global Health
 doi: 10.1136/bmjgh-2020-004107:e004107. 6 2021;BMJ Global Health, et al. Ohuma EO
 47 
Supplementary File 11: A sensitivity analyses of SITAR models fitted to 
the Demographic Health Survey data of 145 surveys (64 countries) from 
2000 to 2018 classified according to the World Bank regions 
 
 
World Bank region classification 
 
 





Sub-Saharan Africa (n=83) 70.3 69.0 
East Asia and Pacific (n=7) No convergence No convergence 
Europe and Central Asia (n=10) No convergence No convergence 










South Asia (n=13) 70.0 71.3 
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Supplementary File 12: Correlation and linear regression analyses of the 
SITAR size and intensity parameters with average starting height from 
birth to 2-months of age (proxy of fetal growth) 
 
Model specification  
Coefficient (95% CI)  Correlation  
Adjusted 
R-squared 
Boys       
Postnatal size vs Starting height at 2-
months 0.56 (0.36 - 0.76) 0.41 
0.165 
Postnatal intensity vs Starting height 
at 2-months 0.67 (-0.11 - 1.44) 0.14 
0.013 
Postnatal size at 2-months vs 
Postnatal intensity 0.26 (0.24 - 0.28) 0.91 
0.826  
Postnatal size vs Starting height at 2-
months + Postnatal intensity    
  
Starting height at 2-months 0.39 (0.32- 0.46) 
N/A  0.903  Postnatal intensity 0.25 (0.23 - 0.26) 
    
Girls    
Postnatal size vs Starting height at 2-
months 0.64 (0.41 – 0.86) 0.43 0.177 
Postnatal intensity vs Starting height 
at 2-months 0.84 (-0.04 – 1.72) 0.16 0.017 
Postnatal size vs Postnatal intensity 0.24 (0.22 – 0.27) 0.89 0.791 
Postnatal size vs Starting height at 2-
months + Postnatal intensity  
  
Starting height at 2-months 0.44 (0.35 – 0.53) 
N/A 0.876 
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